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ABSTRACT

THE ROLE OF DOPAMINE IN MOTIVATIONAL AND RECEPTIVE ASPECTS
OF FEMALE MOUSE SEXUAL BEHAVIOR
by

Amber B. Hodges

Adviser: Victoria Luine, Ph.D.

A pacing paradigm investigated the modulatory role of monoamines in the
mesolimbic dopamine system on copulatory behavior in female mice. Specifically
whether there is a distinction between the neural regulatory mechanisms of pacing
behavior and receptive behavior was determined. Pacing measures motivational and
rewarding components of copulation by the female’s contacts and withdrawals from
the male, while receptivity is the willingness to engage in copulations and is
measured by the number of sexual stimulations received. A pacing paradigm was
established and female mice were observed to pace in a similar manner, but at a lesser
rate, than female rats.
Dopamine (DA) and its pathways regulate copulatory behaviors in female rats
[2, 3]. General and specific DA receptor agonists were used to investigate
dopaminergic mediation of copulatory behavior in female mice. Three doses of
apomorphine (APO; 20pg, 60 pg and 120 pg/kg), a general dopamine agonist, [4]
were given and resulting effects on pacing behavior, receptive behavior, and
dopamine and metabolite levels in brain areas measured. Treatment caused dose
dependent increases in pacing and in DA levels in the Nacc and significantly lower
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levels of HVA/D A in the striatum and Nacc. There results are consistent with
previous studies in rats that show activation of DA terminals in there areas during
reward. The lowest effective dose for altering pacing was 120p,g/kg. APO treatment
was associated with dose dependent decreases in receptivity and significant increases
of HVA in the VMN with a lowest effective dose of 60pg/kg. The VMN is the CNS
regulatory center for receptivity. Since pacing behavior involves locomotor behavior
and APO affects locomotion, subjects were treated with APO and locomotion,
anxiety and exploratory behavior were measured using an open field. APO
dependent increases in locomotion and anxiety and decreases in exploratory behavior
may contribute to its modulation of copulatory behaviors.
In conclusion, a pacing paradigm was established for mice, and results
showed differential effects of DA (dose and brain region) on regulation of
motivational and rewarding vs receptive components fo female sexual behavior. This
information can be utilized in clinical research on sexual dysfunction and drug abuse
involving the DA mesolimbic “reward” pathway.
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I. Specific Aims
This research dissertation uses a pacing paradigm to investigate the
modulatory role of monoamines in the mesolimbic dopamine system on copulatory
behavior in female mice. There is particular interest in establishing a distinction
between the neural regulatory mechanisms of pacing behavior and the neural
regulatory mechanisms of receptive behavior. Additionally pacing behavior is being
used to measure motivational and rewarding components of copulatory behavior.
Dopamine (DA) and its pathways have been shown to regulate other motivational and
rewarding behaviors [5]. Since pacing behavior in rodents is a motivational behavior
[6], we are interested in determining if and/or how DA modulates this behavior.
Therefore the specific aims of this research dissertation are as follows:
(1) Establishment and quantification of baseline pacing and receptive behavior in
female mice. Pacing is a component of female rodent sexual behavior that is
defined by the female approaching and withdrawing from the male, allowing her
to control the frequency and amount of stimulation she receives from the male
[7]. Pacing allows for the quantification of the motivational aspects involved in
copulatory behavior. The pacing behavior can then be compared to receptive
behaviors. Receptive behaviors allow the male to successfully copulate with the
female. The lordosis posture and allowing mounts and intromissions are
considered to be receptive behaviors (see [1, 7] fora review of rodent female sex
behavior).
(2) Investigation of the modulatory role of neurotransmitters on both pacing and
receptive behaviors. Of particular interest is the regulatory role of DA and its
metabolites in the nucleus accumbens (Nacc), striatum and ventromedial nucleus
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of the hypothalamus (VMN). This aim was accomplished by quantifying pacing
and receptive behavior and measuring levels of DA and metabolites in brain
areas important for sexual behavior and motivation.
(3) Investigation of the role of DA receptors mediating pacing and receptive
components of copulatory behavior. The contribution of DA receptors to the
regulation of pacing and receptive behaviors is of particular interest. This aim
was accomplished by administering general and specific DA receptor agonists
and measuring pacing and receptive behavior.
Although there are new animal models available in the form of transgenic and
knockout mice, these genetic models have not been widely used in neuroendocrine
studies because paradigms have not been established for mice [8], Specifically, when
examining sexual behavior, a pacing paradigm needs to be established. Once a
pacing paradigm exists for wild type mice, it can be utilized to study the relationship
between hormones, neurotransmitters and sexual behavior in female mice. With this
information, we can continue to study the motivational and rewarding aspects of
copulatory behavior in female rodents. Primarily these types of investigations have
been confined to rats [1, 6, 7, 9], However expanding our understanding of the
various components of copulatory behavior to mice, will allow for further
investigation of the underlying mechanisms of how neurotransmitters and hormones
affect sexual behavior. Knockout and transgenic mice allow researchers to examine
and gain an improved understanding of sexual behavior, fertility, infertility and
sexual performance problems. Understanding these effects is also important because
it gives information on how various medical treatments alter either neurotransmitter

R ep ro d u ced with p erm ission o f th e copyright ow ner. Further reproduction prohibited w ithout perm ission.

3
levels or hormone levels, which affect sexual behavior in animals and humans. In a
broader sense, investigating the regulatory mechanism underlying all components of
copulatory behavior also gives information about the sexual side effects of drugs,
used to treat mental diseases such as depression and anxiety disorders.
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II. Overview of Sexual Receptivity in Female Rats
Studies examining rodent sexual behavior show that the females exhibit
different degrees o f receptivity in female rodents [10], The female sexual response is
dependent on her physiological state [11]. When the female is nonreponsive to the
male mounting attempts, she displays active resistance or rejection behavior [9]. This
can involve rearing on her hind legs and striking the male with her forepaws [9]. If
the male is successful in mounting, the nonreponsive female may roll on her back,
and dislodge the male [9], She can also run away when under the male [12],
When the female is fully receptive, her behaviors are quite different. One of
the most prominent receptive responses is the lordosis posture [13] Lordosis is a
reflexive posture that consists of the female planting her feet firmly on the ground and
dorsiflexion of the vertebral column, causing her rear to be lifted in the air [11].
When her rear is lifted in the air, it allows the female genital to be more accessible to
the male [12]. If the female is very receptive, her back is fully flexed causing her
stomach area to touch the ground [12]
Female rodent sex behavior is divided into three categories which are
proceptive [1], motivational [1, 6, 14] and receptive behavior [1]. Proceptive
behavior is defined as behavioral cues displayed by the female to entice the male to
come and mate with her [1], There are two behaviors that have been observed in the
receptive female rat, which are categorized as proceptive behaviors [1], The first is a
hopping/darting motion, which consists of a stiff legged hop and darting motion away
from the male. The second is ear wiggling [1]. This consists of the female rat
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shaking her head rapidly, which causes her ears to vibrate. These behaviors signal to
the male that the female is willing and ready to mate [1].
Motivational behavior is the female displaying behavior that shows that she is
interested in the male mating with her and is not just displaying a reflexive response
[6]. Pacing is categorized as a motivated behavior [6,14], because the female
controls the frequency and amount of stimulation received from the male by using an
escape mechanism to approach and withdraw from him.
Receptive behavior is facilitating successful mating by allowing accessibility
of appropriate genitals. The lordosis posture is categorized as receptive behavior
[12]. Receptivity can be measured using the lordosis quotient (number of lordosis
postures divided by the number of mounts), lordosis quality score (quality of lordosis
posture ranked from 0, no dorsoflexion of ventral column, to 3, dorsoflexion of
ventral column and stomach touching the ground) [15] and number o f stimulations
(mounts, intromissions and ejaculations) received.
Lordosis
Initially, female rat sexual receptivity was quantified using a Copulatory
quotient, a measure used to quantify the lordosis response when the female was
mounted by the male [16]. Lordosis is a reflex behavior which is activated by the
stimulation of the male’s mount [11] (see Fig. 1). Estrogen and progesterone enhance
the probability that lordosis will occur following a mount [10]. Many studies have
shown that intact female rats will display lordosis during the proestrus phase of the
estrus cycle [7, 12] (see Fig 2.). Ovariectomized (OVX) female rats, when
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administered estrogen and progesterone in a pattern that mimics the natural estrus
cycle will also display high levels of lordosis responding [7,12, 16-18].
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Figure 1: Female ra t displaying lordosis posture. The Sprague Dawley (white)
female rat is displaying the lordosis reflex when the Long Evans (black and
white) male rat is mounting her. Her feet are planted firmly on the ground,
dorsoflexion of verterbral column, and her head and rear are lifted in the air,
allowing her genital to be accessible to the male [19].
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Figure 2: The days of the 4-day estrous cycle (metestrus, diestrus, proestrus, and estrus). The
nights are represented by the dark bars on the X axis. Behavioral estrus usually begins on the night
of proestrus. This study as well as others mimic the estrus cycle in OVX female rats by
administering estrogen 48 and 24 hours before sexual testing and progesterone 5 hours before
testing[l)

OVULATION

BEHAVIORAL
ESTRUS

METES1RJS

DIESTRUS

PROESTHJS

ESIHU3

DAYS OF ESTROUS CYCLE

Additional experiments have examined the regulatory role of DA on lordosis
behavior [20]. They found that when ovariactomized (OVX )female rats, primed with
high doses of estrogen, are infused with DA receptor antagonists, haloperidol and aflupenthixol, in the hypothalamus, lordosis behavior was significantly depressed [20],
Subsequently, when either apomorphine (APO), a general DA agonist, or DA were
infused in the hypothalamus, lordosis was elevated [21]. In addition, when APO was
administered in place of progesterone, lordosis behavior was also elevated [21].
When APO was administered to OVX females, primed with estrogen and
progesterone, lordosis behavior increased [22], There was also an increase when
APO was given instead of progesterone [22]. Additional experiments substituting
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DA agonists and antagonists for progesterone, found that APO and SKF 38393 (Di
agonists) mimicked effects of progesterone and facilitated lordosis behavior in female
rats. Quinpirole (D2 agonist) had no effect on lordosis [23]. Similar to female rats,
female hamsters show high levels of lordosis when administered D2 receptor
antagonists, sulpiride and raclopride [24]. However, place conditioning (a
measurement of an appetitive process which signifies reward) was reduced or
eliminated [24]. Overall, results of previous experiments show that administration of
DA or its agonists increases receptivity in female rodents. Moreover, stimulation of
Di receptors increases receptivity while stimulation of D2 receptors decreases
receptivity in female rodents.
Pacing
Data from studies on receptivity of female rats, led to research examining
solicitation behaviors that interact with male copulatory behavior [7, 25].
Solicitation behavior can include the proceptive female behaviors of ear wiggling,
darting and hopping. These behaviors are seen in receptive females who are not
allowed to pace [7]. There is now evidence for different neural mechanisms that
regulate proceptive, motivational and receptive sexual behaviors [7]. For the
purposes of this research dissertation, the neural mechanisms that modulate pacing
behavior will be discussed. Pacing mimics more closely the natural sexual behavior
o f rodents [7]. It is observed in natural settings and large environments, and therefore
provides an assessment of more natural female sex behavior [2], In laboratory
experiments with rats, pacing occurs in chambers that have exit holes, which allow
females to enter/exit the chamber of the male [7]. (see Figs. 3-4)
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Figure 3: A schematic drawing of a pacing chamber used with female rats. The pacing chamber
consists of a testing chamber separated by a Plexiglas barrier. The Plexiglas barrier has three
enter/exits holes which are big enough for the female (white rat) to traverse both sides of the
chamber but not the male (black and white rat). This allows the female an escape mechanism
which allows her to control the amount and frequency of stimulation received [26].
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Figure 4: A schematic drawing of a bilevel pacing chamber. The testing chamber is narrow,
which maintains a male and female rat in the optimal orientation for the observer to view sexual
behavior, i.e., in the side view. Moreover, the chamber consists of an upper and lower level,
which allows the females an avenue of escape from the male. Females can level change, by using
the ladders on either side of the chamber to switch levels and escape the male. The chamber is
used to evaluate lordosis and pacing behavior[27].

m
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The sexual stimulations given by the male to the female are mounts,
intromissions and ejaculations [1]. The male begins interacting with the female by
smelling her anal and genital area and attempting to mount her from behind [12]. A
mount is when the male holds the female’s hindquarters and thrusts without inserting
his penis into the female’s vagina [12]. Mounts occur first and provide the least
stimulation [1]. If the female is receptive, intromissions are interspersed with the
mounts [1]. Intromissions are the insertion of penis with or without ejaculations [12].
Copulation ends with ejaculation by the male, which is the most intense interaction
[I]. The lordosis reflex is seen in receptive females in response to the male mount
[II]. The receptivity of the female can be measured through the lordosis quotient
(number o f lordosis / number of mounts and intromissions) [16].
Pacing behavior is used to intersperse these stimulations [1], If allowed, the
female rodent will pace these stimulations by using an escape mechanism to approach
and withdraw from the male [7]. This strategy allows her to control the frequency
and amount of sexual stimulation she receives from the male [7], As the intensity of
the stimulation increases, generally the length of the time spent away from the male
also increases [7]. The amount of time it takes the female to return to the male is
referred to as a return latency [7]. Pacing and return latencies are mediated by
vaginal stimulation [7], When the vaginal area is anesthetized females do not pace,
but they remain with the males throughout the bouts of stimulation [7]. Pacing
behavior is seen in virgin rats as well as experienced rats, and return latencies are not
altered by practice with or exposure to the male [7]. Also, estrogen and progesterone
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administered to OVX female rats in a pattern mimicking the natural estrus cycle, can
induce pacing behavior at the same level of naturally cycling female rats [28].
Reproductive Consequences o f Pacing: Why do females pace? Why is this behavior
interesting or relevant? Pacing behavior facilitates the likelihood of pregnancy or
pseudopregnancy in female rats [18] [19]. Several studies have shown that fewer
intromissions are needed to induce pregnancy or pseudopregnancy when sexual
behavior is paced, compared to non paced sexual bouts [29]. In addition, if a female
receives an ejaculation during a paced mating bout, she is more likely to get pregnant
than if the sexual bout was not paced [28], In pacing bouts, there are also longer
inter-intromission intervals, which are more similar to natural settings, and are
associated with a high proportion o f females becoming pregnant [30]. Mating
patterns, specifically intromissions, induce surges of serum prolactin, which persist in
intact females for 12 days and define the period of psuedopregnancy [21]. In paced
mating, less intromissions are needed to induce these serum prolactin surges
compared to non-paced stimulation [29]. In addition, paced copulation increases the
rate that estrous behavior declines toward the end of estrous[31]. Usually in female
rats, large numbers of intromissions are needed to terminate estrus [29], However,
when allowed to pace, the vaginal-cervical stimulation seems to have a greater effect
on estrus termination [31]. The need for less intromissions in order to induce
pregnancy, pseudopregnancy, and termination of the estrus cycle, during paced
copulation is due to the female rat being able to distinguish between the intensity of
vaginal-cervical stimulation received during each copulatory mount [28]. Thus paced
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stimulations overall seem to have more of an effect than non-paced stimulations on
neuroendocrine changes that are induced by mating behavior [21].
Neural Basis o f Pacing Behavior: Estrogen and progesterone are well known
endocrine regulators of pacing behavior. However the neural regulation is much less
understood. Some studies have investigated neural sites that are sensitive to estrogen
and progesterone and therefore considered to be involved in pacing behavior.
Previous studies examining the neural regulation of lordosis found that the VMN
mediates lordosis so it is a likely site to begin studying pacing behavior[32-36].
Implanting estradiol and progesterone in the VMN has been shown to stimulate
lordosis in OVX female rats [3 7], while lesioning the VMN, reduces lordosis behavior
[38, 39] and the number o f approaches to the male [36]. The number of approaches
did not increase when VMN lesioned females were treated with exogenous estrogen
and progesterone [40]. This pattern suggests that damage to the VMN disrupts the
pattern of approach to the male and ultimately disrupts the amount of coital
stimulation that the female receives from the male.
Other studies have focused on the efferents projecting laterally from the VMN
to the midbrain. Lesioning parts of the midbrain that receive efferents from the VMN
have decreased or eliminated lordosis behavior, however, proceptive and motivational
behaviors such as hopping, darting and pacing were not affected [39]. This was seen
in both intact and OVX females [39]. Additionally, lesions in the ventral
noradrenergic bundle (VNAB) eliminate lordosis but not preeopulatory and pacing
behaviors, and sometimes enhance these behaviors [40].
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Because pacing underlies the female rat’s ability to discriminate between
different types o f coital stimulation, pacing behavior may be controlled by areas in
the brain that serve as terminals for vaginal-cervical sensory information.
Additionally, since pacing behavior enhances the effect of mating stimulation that
induces serum prolactin surges, the same brain areas might be involved [41], The
preoptic area of the hypothalamus (POA) tonically inhibits the nightly surge of serum
prolactin following cervical stimulation and, when lesioned, these surges are
repetitive [29]. Additionally, neurons responsive to vaginal-cervical stimulation are
located in the POA [41], But does it have a role on pacing behavior? When the POA
was lesioned in females that are not allowed to escape from the male, lordosis was
increased and enhanced [42], However, when POA lesioned females were allowed to
pace, there was no increase in lordosis. Additionally, there were decreases in time
spent with sexually active male, number of copulatory mounts received and lordosis
poses [43].
The data supports the idea of separate of neural controls of proceptive,
motivational and receptive components of female rodent sexual behavior. When
some areas o f the brain VMN and VNAB are lesioned, lordosis behavior, but not
pacing behavior is affected [39,40]. In addition, brain areas, such as the POA, that
are important for prolactin surges of pseudopregnancy and pregnancy [44] may also
be important in pacing behaviors.
Description o f Female Mice Sexual Behavior
Female mouse sexual behavior varies from female rat sexual behavior.
Studies examining estrogen receptor knockout (ERKO) [45, 46] and progesterone

R ep ro d u ced with p erm ission o f th e copyright ow ner. Further reproduction prohibited w ithout perm ission.

16

receptor knockout (PRKO) [47,48] female mice and sexual behavior have described
female mouse sexual behavior. Either wildtype [49, 50] or Swiss Webster [45, 51]
males are used as stud males and there does not appear to be a difference in
responsiveness from the female mice. The sexual tests can be conducted in the male
home cage [45,46, 51] or a separate testing chamber [49, 50]. If tested in a separate
chamber, stud males have to be habituated for one hour in the test chamber before the
female is introduced [49]. Testing time varies but sessions are usually thirty minutes
long [45, 46] or terminated after a specific quantity of stimulations, such as 15
mounts [49].
Mounts in mice are defined as both male’s forepaws on the female’s rear [47].
Since the lordosis posture is not as rigid in female mice as in female rats, lordosis is
defined in mice as all four paws being grounded, hind region elevated from the
bottom of the test chamber and the dorsiflexion of the vertebral column. A lordosis
quotient is calculated by dividing the number of lordosis postures by the number of
mounts for each mouse [47]. Receptivity scores are calculated for each female mouse
and are based on normal female behaviors such as squeaking, attempts to avoid
mounts, rearing and kicking [47]. Receptivity scores given to wildtype females
treated with estrogen and progesterone were approximately 65% and averaged 22
total mounts and 15 mounts with intromissions [50]. Subjects also showed 20%
rejection behavior [46], In addition to lordosis, sexual behavior in female mice also
includes male and female approaches, female rejection behavior (fleeing, biting,
kicking) and holding the still receptive posture with and without lordosis. During a
thirty minute testing period female mice average approximately 35 sexual bouts
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which are defined as sexual behaviors occurring in succession by the male, female or
both mice until the mice are separated for more than half a body length [46],
When studying sexual behavior in mice, there are noteworthy strain
differences that must be accounted for, in addition to experimental factors.
Comparing the 129S6/Sv/Ev to the C57BL/6 strain is important because they are the
parental strains of genetic mouse models [8 ]. When analyzing sexual behavior with
these strains, several observations should be taken into account. When the female
mouse is OVX, hormone replacement is necessary to achieve sexual behavior;
however, estrogen alone will not induce high levels of lordosis and receptivity in
either 129S6/Sv/Ev or C57BL/6 strains [48].

Administering progesterone along

with estrogen to either strain results in high levels of sexual receptivity [48].
Lordosis quotients are higher for female mice primed with high doses of estrogen and
administered progesterone than females primed with lower doses of estrogen [48].
To achieve maximal receptivity, both strains required weekly priming for six
weeks with estrogen along with weekly testing[48]. However with equal hormone
priming and testing, strain differences are still evident [48], When high levels of
estrogen and progesterone are administered, C57BL/6 females respond better
thanl 29S6/Sv/Ev [48]. After six weeks of hormone treatment and testing, C57BL/6
mice have a LQ of approximately 80 while 129Sv/Ev mice have a LQ of
approximately 60 [48]. Regardless of the strain, mice require sequential hormone
treatment and testing experience to achieve maximal receptivity [48].
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III. Dopamine and its Pathways
Sexual behavior in rodents has been used to examine the relationship between
hormones, neurotransmitters levels and behavior. Our lab, as well as others, has
examined sexual behavior in female rats to learn more about the role of
neurotransmitters and hormones on sexual behavior [17, 18, 52-54]. These
experiments have used pharmacological approaches such as administering agonists or
antagonists or surgical approaches such as lesioning specific brain regions. DA and
its pathways have been shown to regulate other motivational and reward behaviors,
such as drug seeking behaviors [55-60]. Since pacing behavior in rodents is a
motivational behavior, this dissertation wanted to determine whether DA contributes.
Dopamine Pathways
Mapping studies have estimated that DA constitutes eighty percent of the total
brain catecholamine content [4], Nerve cells containing DA are found in relatively
rostral parts of the brain, including midbrain, hypothalamus and olfactory bulbs, and
their projections are both ascending and descending [4]. There are many forebrain
efferents projecting from the midbrain DA cell groups, and the substantial overlap of
the midbrain and forebrain projections is sometimes labeled the mesotelencephalic
DA system [4].
The DA system is divided into numerous pathways [4]. However for the
purposes of this research dissertation, only three will be briefly described, the
mesostriatal, mesolimbic and mesocortical, and the periventricular and
diencephalospinal pathways.
Mesostriatal Pathway
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Cells in the system originate in substantia nigra (ventral tegmental area
(VTA)/A10 and A 8 groups). The dorsal component (nigrostriatal pathway) ascends
through the medial forebrain bundle followed by the internal capsule to innervate the
caudate nucleus, and the putamen (collectively known as the striatum) [61]. There
are approximately 10,000 DA cell bodies in A9 cell group on 1 side of the rat brain
[62], however a single axon from one cell body can branch and result in many
synaptic boutons in the striatum [63]. Numerous synaptic connections from the
striatum make connections with medium sized spiny neurons that give rise to the
output pathways of the striatum [64], The ventral component cells originate in the
VTA and projects to the nucleus accumbens (Nacc) [61]. The ventral component
plays an important role in the reinforcing properties of psychostimulants and possibly
other drugs of abuse [55],

DA cell bodies project to both the striatum and the Nacc

and can have effects on motor functions.
Mesolimbic System
This pathway arises from the DA neurons in the VTA [61]. The VTA is
adjacent to the more prominent DA cell population of the substantia nigra [61], The
axons of these neurons project from the ventral tegmentum to limbic and cortical
areas [61]. Specifically they ascend to hypothalamic tissue and distribute the axons to
regions including the Nacc and prefrontal fields of the cerebral cortex [61], They also
project to the septum, amygdala, hippocampus, nucleus of the diagonal band, anterior
olfactory nucleus, and limbic cortical areas [56], (see Fig. 5)
The mesolimbic pathway constitutes a major part of the DA “reward” system
[65]. This reward system is based on research that shows a DA surge in the Nacc,
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when an animal is exposed to drags of abuse [56]. It is also known that an animal
will self stimulate to exhaustion if stimulatory microelectrodes are implanted along
the trajectory of the medial forebrain bundle [56]. This evidence allowed the DA
afferents to and from the Nacc, to be labeled as a “reward” system [56]. This system
consists o f DA cells in the VTA, being continually inhibited by GABA [56]. When
disinhibited, DA is released and produces a reinforcement that is normally involved
with natural rewarding stimuli such as food and sex [56]. When the term “reward” is
used it is describes behaviors that make an animal exhibit a self-reinforcing behavior.
Reward does not describe a euphoric feeling [56],
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Figure 5: Sagittal projection of the ascending dorsal noradrenergic bundle and
the mesolimbic dopaminergic system depicting four lesion sites (upper panel).
The lower panel displays a coronal section of the rat brain depicting three 6hydroxydopamine injection sites into dopaminergic terminal fields that have
been tested for their effects on cocaine self-administration. Coronal view
corresponds to section A 8920. Reprinted from [66]
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Pariventricular and diencephalospinal systems
Cells bodies for these systems originate in the A ll and are located in the
periventricular gray of the posterior and dorsal hypothalamus and the caudal thalamus
[4]. The local projections project to the medial thalamus and hypothalamic nuclei and
make up the pariventricular DA system [4], Some of the collateral branches of these
fibers form the diencephalospinal system [4], These branches descend through the
dorsal longitudinal fasciculus and terminate in the spinal dorsal gray and the
intermediolateral cell columns (where the sympathetic preganglionic neurons are
located) [4], Dual innervation of the periventricular system (hypothalamic) and
diencephalospinal system(sympathetic preganglionic cell groups) by the A11
dopaminergic neurons may allow for integrated control of central and autonomic
components of complex motivated behavior such as sexual behavior [4],
Dopamine Receptors
All DA containing neural pathways contain DA receptors. DA receptors have
at least six members, all belonging to the G protein coupled receptor superfamily
[65], Receptors are categorized as Dj-like and D 2 -like [67]. Di and D 5 comprise the
Di-like receptors and D2 , D 3 , and D4 make up the D 2 -like receptors [67], The De
receptor is an isoform of D2 [67]. (see Fig. 6 )
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Di receptors
Di receptors are distinguishable from D 2 receptors because of their ability to
stimulate adenyl cyclase [68-70], (see Fig. 6 ) These receptors have seven membrane
spanning domains [65], The highest density of the Di receptor is found in the
termination areas o f the mesostriatal system (striatum, Nacc and olfactory tubules)
and substantia nigra [4], Intermediate levels have been found in some nuclei of the
amygdala [4], Low Di levels are located in the neocortex, thalamus, cerebellum,
hippocampus, septum and hypothalamus [4], Di receptors can have a low affinity or
high affinity to agonists (including DA) because of receptor-G protein interactions
[4], High affinity occurs when the receptor is complexed with a G protein [4],
Antagonists do not differentiate between receptors complexed with a G protein and
those that are not [4, 71],
D 2 receptors
D2 receptors have been identified because of their high affinity for
antipsychotic drugs and their ability to either inhibit or not affect adenyl cyclase. [67],
(see Fig. 6 ) D2 human receptors have a 96% homology with rat D2 receptors [72].
As mentioned before, there are two isoforms of D2 receptors (D2 L and D 2 S). These
two isoforms are produced from the same gene by alternative mRNA splicing with
respect to the presence or absence of a stretch of 29 amino acids located on the third
cytoplasmic loop of receptor [67]. Currently there is no evidence of any important
pharmacological or functional differences between D2 L and D2 S [4].
In rats, the highest levels of D 2 binding have been found in the striatum, Nacc,
olfactory tubercle, substantia nigra, pars compacta, and glomerular layer of olfactory
bulbs [4], Intermediate levels have been found in the central nucleus of the
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amygdala, lateral septum and the superior colliculus [4]. It is also interesting to note
that in virtually all areas in which Dj and D2 receptor densities were directly
compared, levels of Di receptors were distinctly greater [73].
Figure 6: Summary of the molecular events that lead to dopamine release. An
increase of Ca2+(as shown by the smaller dots) within the cell is a common
trigger for the release of a neurotransmitter. The diagram shows that the Di
and D5 receptors activate (indicated by the +) adenylyl cyclase (AC) leading to
the production of cAMP. The D2, D3, and D4 receptors, on the other hand, inhibit
it, as indicated by the —] sign shown below.
cAMP is a second messenger that activates other molecules within a cell, causing
the cell to undergo certain changes in response to the increased presence of
cAMP. Adapted from Kandel et al., 2000 [65].
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Dopamine Receptor Mechanisms
Low ejection currents of DA or the selective Di agonist SKF 38393 had no
effect on spontaneous activity of striatal neurons, but potentiated the increase in firing
produced by the excitatory amino acid glutamate [74, 75]. This type of
neuromodulatory action may be a mechanism whereby DA from the nigrostriatal
pathway can enhance the excitatory glutamatergic input from the neocortex to the
striatum (the corticostriatal pathway). At high ejection currents, both DA and
selective Di and D2 agonists mainly exert an inhibitory effect on spontaneous and
glutamate-evoked nerve cell firing [75, 76]. However, some evidence shows that
moderate stimulation of D2 receptors can elicit an excitatory rather than an inhibitory
response [76, 77]. More studies are needed to determine how these mechanisms
relate to behavior regulated by DA systems.
Dopamine autoreceptors
DA autoreceptors are found in terminals, cell bodies and dendrites of DA
neurons [78]. (see Fig. 7) Activation of presynaptic (terminal) DA autoreceptors
inhibits both DA synthesis and release. Activation of somotodendritic DA
autoreceptors causes a reduction in cell firing, which secondarily reduces transmitter
release in terminal areas [79]. Dendrites of DA cells in substantia nigra release DA
[80] and such release is stimulated by membrane depolarization or amphetamine
administration [80, 81]. Dendritic DA release can thus be presumed to be a source of
stimulation of somotodendritic autoreceptors, thereby modulating neuronal impulse
flow and terminate DA release [79]. Early research suggested that DA autoreceptors
effects are mediated by receptors with a D2 -like rather than a Dj pharmacology [82,
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83]. Some research suggests that DA autoreceptors are distinct from classic D 2
receptors [84, 85]. Action of both somotodendritic autoreceptors and presynaptic
inhibitory autoreceptors is mediated by increased opening of potassium channels [8 6 ,
87] which hyperpolarizes the cell membrane and decreases the firing rate of DA
release . In contrast, autoreceptor mediated inhibition of DA synthesis seems to occur
via a reduction of cAMP-dependent activation of tyrosine hydroxylase in nerve
terminals [8 8 , 89].
Autoreceptors are not found in all DA systems. In rats, autoreceptors appear to
be on most ascending DA projections except for those terminating in prefrontal and
cingulated cortices [90]. These differences may account for the higher firing rate of
mesoprefrontal and mesocingulate fibers as compared with those of the mesostriatal
system.
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Figure 7: Presynaptic and postsynaptic area of a DA ending. The key steps in the
synthesis and degradation of DA and the sites of action of various psychoactive
substances at the DA synapse.
1. Enzymatic synthesis. The conversion of tyrosine to DOPA
(dihydroxyphenylalanine) by tyrosine hydroxylase is stimulated by L-DOPA
and blocked by the competitive inhibitor a-methyltyrosine.
2. Storage. Reserpine and tetrabenazine interfere with the uptake and storage of
DA by the storage granules. Reserpine is an effective antipsychotic drug; the
depletion of DA by reserpine is long lasting and the storage granules appear to
be irreversibly damaged. Tertrabenazine also interferes with the uptake and
storage mechanism of the granules but only transiently.
3. Release. Amphetamine and tyramide enhance DA release from dopaminergic
neurons by blocking reuptake. Amphetamine induces a psychosis that is
reversed by psychoactive drugs.
4. Receptor interaction. Typical antipsychotics such as perphenazine and
haloperidol are particularly effective in blocking the D2 and the presynaptic
autoreceptors.
5. Reuptake. DA activity is terminated when DA is taken up into the presynaptic
terminal. Amphetamines, cocaine and benzotropine are potent inhibitors of the
reuptake mechanism.
6. Degradation. DA present in a free state within the presynaptic terminal can be
degraded by the enzyme monoamine oxidase (MAO). Pargyline is an effective
inhibitor of MAO. Some MAO is outside the dopaminergic neuron. DA can
also be inactivated by the enzyme catechol-O-methyltransferase (COMT), which
is believed to be localized outside the neuron in the postsynaptic cell.
Adapted from Kandel, Schwartz and Jessel 2000 [65]
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Dopamine receptor agonists and antagonists
Apomorphine (APO) is a general DA receptor agonist [71]. APO treatment in
humans can cause nausea and vomiting. Clinically, it has been used as an emeric
after oral ingestion of certain poisons or drug overdoses [71]. Fortunately, rats and
mice are incapable of vomiting. The mode of action of APO is to stimulate D2
mediated receptors in the chemical trigger zone of the medulla oblongata of the brain
[71]. Even though APO seems to affect D2 mediated behavior effects, it is not overly
selective for D2 over Di receptors [71]. APO has a higher affinity for presynaptic
autoreceptors that for postsynaptic DA receptors [71]. Low does of APO diminish
dopaminergic neurotransmission by selectively activating autoreceptors [4]. High
doses stimulate dopaminergic functions by acting directly on postsynaptic receptors
[4].
Many drugs that are agonists and antagonists of DA are available (see [4] for
details). DA general antagonists of DA include haloperidol, pimozide, and
flupenthixol. Di receptor agonists include SKF38393, SKF81297, SKF82958, and
SKF82526. Di antagonists include SCH23390 (also has an affinity for 5-HT2
receptors), SKF83566 and NNC-112, NNC-756 and SCH 39166. D 2 agonists include
quinpirole and LY-163502, while D2 antagonists include sulpride and raclopride [4].
Behavioral Effects o f Apomorphine
Numerous studies have investigated APO’s effects on various behaviors [9197]. For the purposes of this dissertation, the behaviors of interest are sexual and
locomotor behaviors. Locomotor behaviors are important to study because
copulatory behavior, specifically pacing, involves locomotor activity and are an
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essential part of pacing behavior. Generally, in both rats and mice, low doses of APO
produce hypomotility and yawning, while higher doses produce stereotyped behaviors
such as sniffing, licking and gnawing, [92], Higher doses of APO enhance locomotor
activity in a biphasic way in C57 mice and increase climbing behavior [93].
Particularly, 3mg/kg o f APO produced an increase in locomotor activity and climbing
behavior in comparison with saline[98].
Self administered stimulation thresholds were measured in rats treated with
five doses o f APO and trained to press a lever that delivered electrical stimulation to
the lateral hypothalamus [99]. Low doses caused thresholds to increase while the two
higher doses caused thresholds to drop [99]. The authors hypothesized that the
change in the direction of the behavioral effect corresponds with the shift in APO’s
action from presynaptic activation to predominantly postsynaptic activation of DA
receptors as the concentration of APO increases [99].
Rats administered low doses of APO showed increased yawning behavior
which indicates activating of presynaptic DA receptors. Higher doses result in
induced stereotyped sniffing and yawning which reflects an activation of pre and
postsynaptic DA receptors [96]. The authors further investigated APO’s effect on pre
and postsynaptic DA receptors by administering the Di receptor agonist SKF 38393.
SKF 39393 inhibited yawning induced by low doses of APO [96]. However this
effect can be attenuated if the rat was pretreated with specific Dj receptor antagonist
SCH 23390 [96], High doses of APO induced sniffing and this effect was potentiated
when rats were pretreated with SKF 38393 [96], These data indicate that Di receptor
activation modulates both pre and postsynaptic effects of APO but the effect is in
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opposite directions [96]. In a similar study, rats were treated for 21 days with the
selective Di blocker SCH 23390. One, three, five and eleven weeks following the
chronic treatment they received either a low hypomotility inducing dose or a high
stereotyped behavior inducing dose of APO [97]. The rats always show an enhanced
stereotyped response to the higher dose of APO, but never any change in their
motility to the lower dose of APO [97]. The authors postulate that the results provide
a behavioral correlate of the pre and postsynaptic modulation of APO by Dj receptors
[97]. A critical dose of APO (300 micrograms/.kg s.c.) given immediately before
placing rats into a novel environment produced initial sedation followed by enhanced
locomotion [100]. When these same rats were treated with Di and D2 antagonists, the
APO induced mobility response was inhibited, indicating that APO stimulation can be
antagonized by Di as well as D 2 receptor blockade[100]. However a high affinity for
D2 receptors seems vital for the blockage of APO inhibition [100].
APO effects behavior [91-96,100], receptor activation [100]and DA
metabolite levels [101, 102], Chronically stressed C57BL/6 mice treated with two
doses of APO showed decreased climbing behavior and reduced DA metabolites,
DOPAC, HVA and 3-methoxytyramine (3-MT) concentrations in the caudate
putamen and Nacc compared to non stressed mice. The authors suggest that chronic
stress lead to a sensitization of mesolimbic DA presynaptic receptors possibly by an
associated downregulation of postsynaptic DA receptors in the C57 strain [102],
Acute immobilization stress causes a significant reduction of spontaneous
locomotion and a slight reduction of spontaneous climbing, while ten days of chronic
stress decreased stress induced locomotion and increased stress induced spontaneous
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climbing [94], Twenty four hours after the last stressor, the results were reversed
with increased locomotion behavior observed in the acutely stressed mice and
decreased climbing behavior observed in the chronically stressed mice [94].
Following acute exposure to immobilization stress, DOPAC/DA and HVA/DA ratios
were increased in the striatum and in the Nacc [101], Finally, chronically stressed
mice tested 24 hours after the last stressful experience, showed an increased
sensitivity to the inhibitory effects of low doses of APO on climbing behavior and a
decreased sensitivity to the inhibitory effects o f the same doses o f the DA agonist on
locomotion [101]. These experiments show that APO can activate both pre and
postsynaptic DA receptors depending on dose administered. In addition, stress can
attenuate these APO induced behavioral changes which indicates that stress can
modulate APO’s activation of pre and postsynaptic receptors [94,101].
Factors such as stress and dose are notable because they influence behavioral
activation by pre and postsynaptic DA receptors. These factors can directly affect
both pacing and receptive behaviors, causing unexpected increases or inhibition.
Stress and dose are important to consider when examining the effects o f DA or APO
on female mice copulatory behavior. Currently, there are reports that APO both
facilitates [22] or inhibits [103] copulatory behavior in female rodents . The
discrepancy in reports is probably due to the aforementioned factors.
Behavioral Effects o f Selective DA receptor agonists and antagonists
Systematic doses of Di agonists cause robust stimulation o f grooming in rats
[104]. Direct infusions to the striatum or Nacc can cause patterns of hyperactivity
and stereotyped behavior. D2 agonists, quinpirole or RU 24213 cause increases in
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locomotion, sniffing, and snout contact [105-107]. These changes similar to APO
behavioral effects but are not as robust. These effects can be blocked by both D2 and
Di antagonists as well as endogenous DA depletion [106,108]. Combined
administration of Di and D 2 selective agonists cause more robust effects than either
singly [106,109]. Both Dj and D 2 selective antagonists can also cause catalepsy
[110].
Dopamine, Estrogen and Progesterone
Administration of estrogen and progesterone to OVX female mice facilitates
sexual behavior [48], Research has shown that estrogen and progesterone have
genomic and nongenomic effects that are mediated by interacting with DA receptors,
uptake sites, and DA levels [23, 111-121], Genomic effects have a long latency and
require a specific hormone-receptor interaction, specifically translocation of the
complex to the cell nucleus and subsequent induction of specific hormone-sensitive
proteins [114] Nongenomic effects are rapid in onset, recoverable and stereospecific
[114]. Both types o f effects are important to mention in the context of this
dissertation because the behavioral paradigm used as well as past research requires
that OVX female rodents are administered estrogen and progesterone either acutely or
chronically [ 1 ,

11

]

While the main focus o f the current research was on DA concentrations in the
striatum and Nacc because they are part of the mesolimbic “reward” system, the
interaction between DA, estrogen and progesterone should also be considered. In the
paradigm used in this dissertation, all animals were treated with estrogen and
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progesterone to initiate sexual behavior. Therefore, the interaction effects of
hormones with DA, its metabolites and its receptors warrant further discussion.
Estrogen and DA
Estrogen replacement is essential to achieve maximal receptive behavior in
OVX female rodents. Estrogen has genomic effects in the brain including inducing
progesterone receptors that facilitate copulatory behavior. Several studies have
investigated the interaction between estrogen and DA levels [115, 122], receptors
[120,123]and transporters [117] in the mesolimbic DA system . When the female rat
is OVX, extracellular DA concentrations and DA transporter density decreases [103,
122] and Di receptor density is decreased compared to gonadally intact rats [123]. In
comparison, high affinity D2 receptor sites increase and supersensitivity of striatal D 2
receptor binding sites develops over 2-3 months [120].
When estrogen is administered to OVX rats, there is a rapid release of DA in
the striatum, an increase in striatal DA turnover and a downregulation of D2 receptors
in the striatum [118, 124], Acute estrogen has also been shown to act directly on the
Nacc to enhance potassium stimulated DA release [114], In vivo voltammetry shows
that local injections o f 17B-estradiol produce rapid and dramatic increases in
stimulated DA overflow in the Nacc [114]. When a physiologically dose is given
acutely to OVX female rats, DA turnover is increased in both the striatum and Nacc,
while DA concentrations remain the same [118]. OVX females treated with chronic
estrogen show a reduction of DA concentrations in both the striatum and Nacc, and
no effect on DA turnover [121], Although there is less research on estrogen effects in
the Nacc, research suggests that the mechanisms are similar to the striatum [121].
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When DA transporter levels were compared in short term versus long term
OVX female rats before and after treatment with estrogen, several interesting results
were found [117]. Compared to intact females, both short and long term OVX
females showed a significant decrease in DAT density in the striatum, and the long
term OVX females also showed a decrease in the Nacc [117]. DAT density was
restored in striatum but not in the Nacc, of short term OVX females that were treated
with estrogen [117]. Estrogen treatment did not change the DAT density levels in
the striatum of the long term OVX females but it did restore levels in the Nacc [117],
This information is relevant to this dissertation for several reasons. All female
mice used in these experiments were OVX and administered estrogen both acutely
and chronically. The length of time that females were OVX before they receive
hormones directly affects DA levels, its receptors and transporters. In view of the
fact that this dissertation research measured DA, receptors and metabolites in the
striatum and Nacc, the time between the ovariectomy and the estrogen administration
is critical.
Progesterone and Dopamine Interactions
Several studies show that estrogen induced progesterone receptors mediate
progesterone effects on sexual behavior in rodents [47, 48]. Progesterone receptors,
like estrogen receptors are ligand inducible members of a superfamily of transcription
factors that undergo significant conformational change upon ligand binding [47],
Studies using progesterone receptor antagonists and protein synthesis inhibitors
consistently demonstrate the mediating role of intracellular progesterone receptors on
sexual behavior[48] [47]. Progesterone’s genomic effect on sexual behavior was

R ep ro d u ced with p erm ission o f th e copyright ow ner. Further reproduction prohibited w ithout perm ission.

35
demonstrated in these studies [47]. However there is also evidence that progesterone
has nongenomic effects on sexual behavior, possibly mediated through effects at the
membrane [47], The minimal receptivity response of progesterone receptor knockout
mice (PRKO) given progesterone implies that membrane bound progesterone is not
the primary mediator of the lordosis response in mice [47]. Instead, evidence suggests
that intracellular genomic effects act together with membrane receptor effects to
mediate sexual behavior in rodents [47].
Progesterone receptors are of particular interest because of their interaction
with DA [125]. DA induced sexual behavior in mice requires an unoccupied
progesterone receptor [47]. Positive correlations have been demonstrated between
receptor concentrations in the hypothalamus and the maximal behavioral response,
results which demonstrate the requirement for elevated levels of progesterone
receptor for behavioral responsiveness to progesterone in mice [125].
Experiments with hormone primed PRKO have suggested crosstalk between
progesterone receptors and DA [125]. Wildtype and PRKO were administered the Di
agonist, SKF 39393, but only wildtype female mice exhibited high levels of
lordosis.[125] The PRKO showed minimal responses to both progesterone and Di
agonists [125]. These results suggest that progesterone receptors mediate DA’s
contribution to sexual behavior. [125].
DA is released in the striatum when estrogen primed female rats are treated
with progesterone [9], Furthermore after estrogen priming, a membrane associated
protein with a high affinity for progesterone has been isolated from the striatum [9].
These effects of progesterone on striatal DA release are not seen without estrogen
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priming [9]. Studies comparing the effect of repeated estrogen with either acute
estrogen or progesterone treatment find prior exposure to estrogen enhances the
effects of subsequent estrogen or progesterone treatments on AMPH-stimulated DA
in dialysates from the dorsal lateral striatum[9]. In addition, significant increases of
DA in the Nacc and striatum occurred concurrently with DA release in the VMN in
the female during copulation [9].
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IV. The Role of Dopamine in Sex Behavior
DA is a mediating factor in sexual behavior, specifically for incentive,
motivation and reward. When sexually sluggish male rats are administered APO (a
general DA agonist), copulatory behavior increases [126]. Sexually active male rats
administered haloperidol (general DA antagonist), display decreased sexual behavior
and motivation [127], APO injected into the ventral tegmental area (VTA) delays
onset of copulation and slows its rate. These males showed fewer complete
copulatory behaviors (mounts, intromissions), and more misdirected copulatory
attempts, implicating that the VTA affects motor but not motivational aspects of male
rat sexual behavior [128, 129].
Experiments that administered selective DA agonists and antagonists in the
medial preoptic area of male rats found the following results: the D 2 agonist, LY163502 delayed the onset of copulation and slowed the rate of copulation [130]. A
reduced number of vaginal intromissions were required to reach ejaculation [130].
The Di agonist, SKF-82526 had no effect alone or in combination with LY-163502
[130]. The Di antagonist SCH-23390 delayed the onset of copulation and decreased
ejaculatory threshold (the number of vaginal intromissions required to trigger
ejaculation) [130]. A low dose of D2 agonist alone and with the Di antagonist
delayed onset of copulation and reduced ejaculatory threshold [130]. This data
suggests that stimulating D 2 receptors or blocking Dj receptors delays onset of
copulation and reduces ejaculatory threshold. Overall, this data indicates that DA, or
its agonists, increase receptivity. Additionally stimulation of Di receptors increases
receptivity, while stimulation of D 2 receptors decreases receptivity [130]
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Additional studies have shown that the Di antagonist, SCH-23390 and the D2
antagonist, raclopride injected into the medial preoptic area (MPOA) decreases the
sexual motivation of male rats [131]. Additional evidence of DA modulating sexual
behavior comes from work examining extracellular DA in the mPOA [132]. In male
rats, there are changes in DA release during copulation in brain areas that play a role
in reward and motivation aspects [132], Specifically, DA is released in the mPOA
during copulation and in other DA pathways during encounters with a receptive
female [132]. These dopaminergic pathways underlie the motivational and reward
aspects of sexual behavior. Specific increases are found in the nigrostriatal system,
which enhances readiness to respond to stimuli as well as the mesolimbic system,
which is critical for numerous types of motivation [133]. As mentioned previously,
there are also increases in the mPOA which focuses motivation onto specific sexual
targets, increases copulatory rate and efficiency, and coordinates genital reflexes
[134]. The increase o f DA in these three areas generally enhances sensorimotor
integration by removing tonic inhibition. Therefore, steroid hormones increase the
responsiveness of certain neurons but only after DA removes tonic inhibition.
Ascending DA projections to the Nacc are also involved in sexual behavior of
the male rat. Several studies show an increase in DA in the Nacc of the male rat
during sexual behaviors [135,136] and it is important to determine if similar changes
occur in females during sexual behavior. Extracellular DA increases in the Nacc of
male rats during copulation as well as during exposure to stimuli that has been
previously associated with a receptive female [135,136], These data suggest that, in
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the male rat, DA release in the Nacc is associated with incentive or motivational
behavior.
Findings that DA increased in both the mPOA and the Nacc during sexual
behavior led researchers to examine if this effect occurs in female rats. DA
transmission in female rats has not been studied as extensively as in male rats. In
studies examining DA in the mPOA during female sexual behavior, DA levels were
increased when a hormone primed female became receptive as well as when
copulating with a male [137], The increase of DA during copulation only occurred
when the male and female were confined in the same arena [137]. However, when
the female was allowed to pace her contacts with the male, no increase in DA was
seen in the female mPOA during copulation [137]. DA levels in MPOA were also
measured in vivo during sexual activity after priming with estrogen and progesterone.
DA levels increased when females were primed with low levels of estrogen and given
500 pg of progesterone. Further increases in MPOA DA occurred when females
copulated in non pacing chambers, and when they were allowed to pace, DA
metabolites rose during copulation [137].

Single unit activities, recorded from Type

1 neurons in POA of female rats while copulating, were increased when the female
rats initiated proceptive behavior [19]. Type 2 neurons showed brief activity when
the male mounted [19], Type 3 neurons fired in response to intromission, and type 4
were inhibited throughout lordosis [19].

Type 1-3 neurons were recorded from the

transitional regions between the medial and lateral POAs [19]. Type 4 neurons were
located more medially in the medial POA. Systemic injections of pimozide (a DA
receptor blocker) diminished firing in type

1

neurons and abolished proceptivity [19].
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The firing pattern in type 1 neurons appears to represent the motivational state of rat
and has implications for consummatory value of penile intromission [19].
The role of DA transmission in both the striatum and Nacc has also been
examined in estrogen and progesterone primed hamsters. Vaginocervical stimulation
was correlated with elevated DA levels in the Nacc [138]. Estrogen treated female
rats also had enhanced increases of DA in Nacc compared to vehicle treated females
[2]. DA levels, in striatum, increased more in OVX, hormone primed, female rats
that paced copulation than in female rats that did not pace copulation [3]. Female
rats that paced also showed a greater increase of DA in Nacc [3]. Lesions of the
striatum reduces pacing and lesions to the shell of the Nacc causes failure of females
to initiate sex prior to a sexual contact [139].
Results from numerous studies have shown an important modulatory role of
DA on sexual behavior in female rats. These results have lead to this investigation of
the regulatory role o f DA on sexual behavior in female mice. Further investigations
using mice will broaden the understanding of the role of DA in female sex behavior.
Moreover, the possibility of investigating behavior in mice, which overexpress
(transgenic) or do not express (knockout) specific components of DA neurons,
provide a unique advantage of a mouse model. Establishment of a mouse model will
allow further exploration of the regulatory roles of DA and its receptors on the reward
system involved with sexual behavior. This new model will compliment current
pharmacological studies already existing in with rats.

The combination of

information from rats and mice models may increase understanding of evolutionary
and genetic differences underlying neural mechanisms of behavior.
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V. Research Design and Methods - General Experimental Design
Animals
Animals used in this series of experiments were six week old C57BL/6N Tac
or 129S6/Sv/Ev black female mice. Subjects were OVX at Taconic Farms prior to
arrival at the Hunter College Animal Facility. Subjects were doubly housed with
food and water ad lib and maintained on a 12-hour light/dark cycle. To ensure that
males were larger than females, twelve week old Swiss Webster males served as stud
males. Males were housed individually and received food and water ad lib.
Injections
Each female received injections of 10 pg estradiol benzoate 48 and 24 hours
before testing and 500 pg progesterone five hours before testing. These injections
have been shown, in both rats [7, 139] and mice [46, 47, 50], to induce sexual
receptivity. None of the males received injections.
Pacing Apparatus
The pacing apparatus consisted of the male’s home cage with the addition of
two Plexiglas cubes with a small opening. The openings are large enough for the
female, but not the male, to enter and exit. The male’s home cage is thirteen
centimeters high, eighteen centimeters wide and twenty-nine centimeters long. Both
the male and female had access to the entire cage. However, only the female had
access to the inside of the cubes, but the males frequently tried to enter the cubes and
sat on top of the cubes. The pacing cubes remained in the male’s homecage during
the testing session and were removed following completion of testing. During
testing, the male’s homecage was covered with Plexiglas instead of the wire top.
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This change ensured that the subjects would not be distracted by food, water or
climbing on the cage top. Because mice are exploratory, it was necessary to
acclimate them to the chamber prior to testing. Pacing cubes remained in the
female’s homecage from a week after their arrival until they were sacrificed. This
procedure allowed acclimation to the cube and ease of traversing through the small
opening. The male was exposed to the pacing cubes five hours prior to testing, so
that the male would be interested in the female, not the cubes, during sex behavior
testing.
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Figure 8: Pacing Chamber for Mice. Two chambers are shown. Each chamber
consists of the male’s homecage to which two Plexiglas cubes have been added,
the cubes have small openings that only the female can fit through. The cubes
allow the female an escape mechanism so that she can approach and withdraw
from the male when desired. The top of the cage is replaced with a Plexiglass
cover.
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Behavioral Testing
Five hours after injection of progesterone, behavioral testing began. The
pacing apparatus was placed in the male’s home cage five hours prior to testing. The
female was then placed in the male’s homecage and the behavioral test began. All
testing sessions were videotaped for behavioral scoring. Two observers recorded the
exit latencies; return latencies after interactions such as mounts, intromissions and
ejaculations as well as the number of mounts, intromissions and ejaculations and
number o f rejections. Exit latencies are the time it takes the female to leave and
reenter the male chamber after stimulations. All sessions lasted thirty minutes or
until ejaculation occurred. The percentage time in the male chamber, the percentage
time in the pacing cubes, the percentage o f leaves after each type of stimulation, the
average time spent with the male, the average time spent in the pacing cubes, and the
percentage of exits after stimulation were also calculated.
Each female was tested once a day, every four days with a maximum of two
consecutive tests. All tests were performed under red light during the dark portion of
their circadian cycle. After completion of testing, the female mice were sacrificed by
rapid decapitation and their brains frozen on dry ice for further neurochemical
analysis.
Monoamine Analysis
Brains were sectioned at 250-300pm at -6 to -8° C in a microtome cryostat.
Nacc, striatum, ventral medial nucleus, vertical diagonal band and amygdala brain
areas were micropunched from sections according to the atlas of Franklin and Paxinos
[140] with a 500 pm diameter cannula while the slide rested on a microscope stage
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which was maintained at - 11.5° C as described by Luine et al., 1999 [141], The
monoamines and metabolites DA, DOPAC, HVA, serotonin, 5HIAA and
norepinephrine were measured. Punched samples were placed in 1.5 ml Ependorf
tubes with 60 pi of sodium acetate buffer containing a-methyl-DA (as internal
standard). After freezing-thawing and centrifugation, the supernatant was removed
and 2 pi o f 1mg/ml ascorbate oxidase solution (Sigma) was added to each sample to
minimize the HPLC front. Forty microliters was injected into a Waters Associates
chromatographic system consisting of a Waters 2690 Separation Module, and
Symmetry Cis-5 pm column. An ESA 5011 Colocomb 3100A electrochemical
detector with the screening electrode set at +0.05 V and the detecting electrode at
+0.35 Y was used. Concentrations of neurotransmitters and metabolites were
calculated by reference to standards using peak integration with a computer assisted
Water Millennium system. Sample runs averaged 30-40 minutes. The pellet was
dissolved in 100 pi of 0.2 N NaOH for protein determination by the Bradford method.
Concentrations were expressed as pg/pg protein [141].
Statistical Analysis
The behavioral data was scored and the number of mounts, intromissions,
ejaculations, rejection behavior, returns latencies after each stimulation, total percent
time spent with the male, total time spent in the neutral pacing cubes, exit latency,
exit after stimulation and total exits after each type of stimulation for each female
mouse were calculated. Descriptive statistics including the mean and standard error
were obtained for each measure. One way ANOVA was used analyze data when a
between subjects design was used and different groups of mice were treated with
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different drugs or doses of the same drug. If ANOVA was significant at the p < 0.05
level, appropriate post hoc test were used to test differences between groups. Linear
regression was used to correlate neurotransmitter levels to the number of stimulations
received. Correlations at the p < 0.05 level were accepted as significant.

VI.

Experiment 1 - Establishment of a Pacing Paradigm for Female Mice

Rationale
Extensive research has examined sexual behavior of female rats and shown
that DA levels increase in specific brain areas when female rats are allowed to pace
and copulate [2, 3, 9]. In comparison, little research has focused on sexual behavior
of female mice. Data from female mouse studies will complement already existing
pharmacological data from female rats. When a pacing paradigm for female mice is
developed, it can be used with transgenic and knockout mice. 129S6/Sv/Ev females
were selected for these experiments because knockouts are developed from 129 and
C57 lines.
Specific Aims
1.

Establish and quantify baseline pacing and receptive behavior in female
mice.

2. Determine monoaminergic neurotransmitters that influence pacing.
Hypotheses
1. Female mice will pace in a manner similar to other small rodents.
2. DA and its metabolites, DOPAC and HVA, will increase in the striatum and
Nacc when female mice are allowed to pace and copulate.
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Animals
Female mice of a 129S6/Sv/Ev or C57BL/6N Tac background were used.
Injections
Female mice of the 129S6/Sv/Ev and C57BL/6N Tac were hormone primed
with 10 pg of estrogen 24 and 48 hours before testing and 500 fig of progesterone
five hours before testing.
Behavioral Testing
The subjects were tested as described in the general experimental methods.
Monoamine Analysis
Immediately following testing, brains removed, sectioned, micropunched and
analyzed using HPLC analysis as described in the general experimental methods.
Statistical Analysis
Linear regression was used to correlate relationships between total stimulations and
monoamine levels in the striatum, Nacc, VDB, and VMN as described in the general
experimental methods.
Results
Female mice of the 129S6/Sv/Ev were not suitable for behavioral analysis
because they were lethargic and exhibited low levels of copulatory behavior. These
subjects showed little interest in the male and rarely used the pacing cubes. In
addition, they showed low receptivity (few mounts or intromissions) (data not
shown). Therefore C57 female mice were utilized for the rest of the experiments.
This strain is also appropriate because they are used to create knockout mice.
Apparatus
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Several apparatuses were evaluated for quantification of mouse pacing. The
first attempt used a scaled down version of an established apparatus for testing of rat
pacing [7] (see Fig 9a). This apparatus consisted of a chamber with Plexiglas barrier
with three enter/exit holes that were too small for the males to fit through but were
large enough for the females.
This apparatus was not suitable for analysis of mouse pacing. The females
would traverse back and forth through the enter/exits holes when they were without
the male. However, when males were place n the chamber, many females would sniff
at the holes, but never cross to the male side. Other females would cross to the male
side but they never crossed back to the female side; thus they did not display pacing
behavior. The greatest problem was that persistent males would attempt to cross
through the enter/exit holes. Some males succeeded at squeezing through the holes,
but others became stuck in the holes and had to be removed.
This apparatus was modified by removing the holes and substituting a solid
wall o f Plexiglas (see Fig. 9b). This Plexiglas barrier was raised above the bottom of
the cage, and allowed for the females but not the males to fit under. Similar problems
were encountered as in the first design. Some females would stick their head under
the barrier, but not completely cross over to the male side. Other females crossed
over to the male side but never crossed back over to the female side. Finally, some
persistent males tried to cross over to the male side and became stuck under the
barrier.
Though these first two apparatuses failed, a consistent trend was noted.
Though the females did not use the enter/exit holes or the barrier to escape the male,
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they did display other behaviors. Specifically, if the male approached a female and
who was unwillingly to be mounted, she would crouch in a comer of the cage and
reject him by kicking and rearing up on her hind legs. This strategy worked
temporarily, but if the male was persistent, he could eventually push her out o f the
comer and overpower her.
Observing this interaction, a new apparatus that utilized the rejection behavior
was devised (see Fig 9c). Plexiglas boxes (7 cm width,

6

cm height, and 7 cm depth)

with small enter/exit holes that the female, but not the male, could fit through were
constructed. These boxes were placed in two diagonal comers of the cage and
allowed the female to escape the male, if desired. If the male attempted to follow her
into the box or put his head into the box, she could kick or nip him to keep him away.
Also, the Plexiglas box protected females from being pushed out of the comer. This
configuration proved to be the best way to measure pacing behavior in female mice.
The small boxes gave females an escape mechanism from the male and allowed the
female to approach and withdraw from the male when she desired.
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Figure 9a: Scaled down version of an established apparatus for testing of rat pacing. This
apparatus consisted of a chamber with Plexiglas barrier with three enter/exit holes that were too
small for the males to fit through but were large enough for the females.
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Figure 9b: Modified pacing apparatus for testing of mouse pacing. This apparatus was modified
by removing the holes and substituting a solid wall of Plexiglas. The Plexiglas barrier was
raised above the bottom of the cage, and allowed for the females but not the males to fit under.
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Figure 9c: Successful apparatus used in experiments. Plexiglas boxes (7 cm width, 6 cm height,
and 7 cm depth) with small enter/exit holes that th e female, but not the male, could Fit through
were constructed. These boxes were placed in two diagonal corners of the cage and allowed the
female to escape the male, if desired.
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Behavioral Measures in Pacing Females
Utilization of C57 females and Plexiglas escape cubes in the male home cage
enabled measurement of female mouse pacing behavior. Pacing behavior in female
rodents differs by species and most research has been done on pacing female rats (see
Table 1). However, a description of female mice pacing behavior is also necessary
and important to further understand female rodent copulatory behavior. Female mice
pacing consists of entering and exiting two pacing cubes, which have a small
enter/exit hole on one side to allow the female to escape and approach the male at
will. In addition to entering and exiting the pacing cubes, the female mice also use
rejection behavior, which consists of kicking, nipping and biting the male if he
approaches her before she is ready to copulate. The pacing cubes, combined with the
rejection behavior allow the female mouse to pace her copulations by providing an
escape mechanism which allows her to control the amount and frequency of
stimulation she receives from the male. Observations from this experiment have
illustrated that female mice use both the pacing cubes and rejection behavior to
escape the male. Therefore quantifying both the frequency of utilizing the cubes as
well as the frequency of rejection behavior displayed provides an accurate assessment
of pacing behavior in female mice. Pacing is quantified by calculating the latencies
to return to the male after receiving a mount, intromission or ejaculation, total number
of rejections and latency to return to the male after rejection behavior. The total
amount of time spent with the male and in the pacing cubes is also calculated.
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Table 1: Comparison of average Pacing Measures between Female rats and Mice.
Mean and SEM. All latencies were measured in seconds.
1. Unpublished observations reported by Luine et a l . , 1998 [142]
2. Observations reported by Erskine, 1989 [7]
3. Unpublished observations reported by Hodges et al., 2004
Percent
time
Spent
with
Male
R 55.00 ±
a 5-0i
t
s
M 77.02 ±
i 7.37s
c
e

Percent
time
spent
away
from
male
45.00 ±
5.0i

Return
Latency
after
Mount

Return
Latency
after
Intromi
ssion

Return
Latency
after
Ejaculat
ion

14.33 ±
5.312

26.05 ±
3.832

12.12 ±
9.56

70.74 ±
1.5 83

55.29 ±
20.023

Percentag
e Exits
after
Intromissi
ons

Percentag
e Exits
after
Ejaculatio
ns

49.00 ±
21.202

Percen
tage
Exits
after
Mount
s
50.50 ±
ll-472

73.57 ±
5.962

100.00 ±
0.02

118.93 ±
12.26s

49.09 ±
2.90s

58.78 ±
33.28s

100.00 ±
0.0s

R ep ro d u ced with p erm ission o f th e copyright ow ner. Further reproduction prohibited w ithout perm ission.

55

As shown in results, receptivity in female mice differs from receptivity in female rats. A
female rat is receptive if she displays the lordosis posture in response to a male mount, which
allows the male to successfully copulate [7]. Therefore, quantifying the frequency and quality of
lordosis (calculating a lordosis score) serves as a measure of receptivity. Female mice do not
consistently display the lordosis posture, which means that lordosis can not be easily used to
measure receptivity. Instead, a female mouse is considered to be receptive if she remains still
and allows the male to mount and intromit, without showing rejection behaviors. For the
purposes of this series of experiments, female mice receptivity was categorized as low, medium
and high. This categorization was developed from previous and current observations of female
mouse sexual behavior in our laboratory (see Table 2).

Table 2: Evaluation of Female Mice Receptivity
This ranking system was developed to determine if a female mouse is displaying low,
medium or high levels of receptivity. Data was derived from behavioral tests using
estrogen and progesterone treated OVX mice using the mouse pacing paradigm of
small Plexiglas cubes in the male homecage.
Behavior
Mounts
Intromissions
Ejaculations
Rejection Behavior

0 -1

Medium
2-5
2-4

High
6+
5+

0

0

1

5+

2-4

0 -1

Low
0 -1
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Monoamine and Metabolite Levels in Pacing Females
OVX females received estrogen and progesterone treatment and were tested for
sexual behavior. Immediately following behavioral testing, mice were rapidly
decapitated and their brains collected and frozen. Brains were sectioned at 250-300 pm
and micropunched as described in the general experimental methods. Levels of
monoamine levels and their metabolites (DA, DOPAC, HVA, HVA/DA 5-HT, 5-HIAA,
NE) were measured in the striatum, Nacc, VMN, and amygdale using HPLC analysis
described in the general experimental design. Thought not significant, a trend was seen
between total stimulations (mounts plus intromissions) and DA, HVA, and DOPAC
levels in the Nacc (see Fig. 10). However, we did not find any other significant
correlations or trends between any other monoamines and amount of stimulations or
pacing parameters (see Figs. 11-13).
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Figure 10: Levels of DA and metabolites in nucleus accumbens plotted versus total
stimulations. Each data point represents one mouse, (n = 6). There was a
significant correlation between DA and total stimulations (r 1,4 = 0.68, p < 0.05).
The correlation was not significant for metabolites and total stimulations including
DOPAC and total stimulations (r 2 1 , § = 0.22, p = 0.30), and HVA and total
stimulations (r2 1,5 = 0.10, p = 0.49).
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Figure 11: Levels of monoamine and metabolites in Amygdala plotted versus total
stimulations. Each data point represents one mouse, (n = 5). There was no
significant correlation found between the monoamine or metabolite levels and total
stimulations in amygdala. This includes DA levels and total stimulations (r2i,4 =
0.02, p = 0.77), NE levels and total stimulations ( r2 1,4 = 0.11, p = 0.51), DOPAC
levels and total stimulations ( r\ 4 = 0.13, p = 0.47), 5HIAA levels and total
stimulations (r2 1,4) = 0.06, p = 0.64), HVA levels and total stimulations (r2i,4 = 0.12, p
= 0.50), 5HT levels and total stimulations (r2 1 ,4 = 0.00, p = 0.98), HVA/DA levels and
total stimulations (r2 1 ,4 = 0.05, p = 0.65), and 5MAA/5HT levels and total
stimulations (r2^ = 0.37, p = 0.20).
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Figure 12: Levels of monoamine and metabolites in VDB plotted versus total
stimulations. Each data point represents one female mouse, (n = 6). There was a
positive correlation between 5HIAA/5HT levels and total stimulations in VDB
(r2 1 ,5 = 0.69, p < 0.02) There was no significant correlation found between the
monoamine or metabolite levels and total stimulations in VDB. This includes DA
levels and total stimulations (r2 1 ,5 = 0.01, p = 0.78), NE levels and total stimulations
(r2 1.5 = 0.00, p = 0.91), DOPAC levels and total stimulations (r2 1,5 = 0.04, p = 0.65),
5HIAA levels and total stimulations (r2i,s) = 0.13, p = 0.42), HVA levels and total
stimulations (r2 1 ,5 = 0.05, p = 0.61), 5HT levels and total stimulations (r2 1 ,5 = 0.04, p
= 0.66), HVA/DA levels and total stimulations (r2 1 ,5 = 0.19, p = 0.33).
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Figure 13: Levels of monoamine and metabolites in VMN plotted versus total
stimulations. Each data point represents one mouse, (n = 5). There was no
correlation found between monoamine levels and total stimulations in VMN. This
includes DA levels and total stimulations (r2 1,4 = 0.02, p = 0.80), NE levels and total
stimulations (r2 1,4 = 0.10, p = 0.55), DOPAC levels and total stimulations (r2 1,4 =
0.10, p = 0.53), 5HIAA levels and total stimulations (r2 1,4) = 0.01, p = 0.82), HVA
levels and total stimulations (r2i,4 = 0.01, p = 0.86), 5HT levels and total stimulations
(r2 is4 = 0.00, p = 0.89), HVA7DA levels and total stimulations (r21,4 = 0.00, p = 0.94),
and 5HIAA/5HT levels and total stimulations (r2 1,4 = 0.07, p = 0.62)
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Discussion
The results from this experiment demonstrated that female mice will pace when a
suitable apparatus is used. Female mice pace at a lower rate compared to female rats
(see Table 1). Observations o f a lessened rate of pacing and receptivity as compared to
female rats may be due to the amount of habituating sessions and hormone treatments.
Hormonal treatments and habituating sessions were based on female rat behavior. In
subsequent experiments, it was discovered that both the male and female mice need at
least three training sessions to begin to show ample copulatory behavior.

Studies

exam ining sexual behavior in PRKO mice have shown that optimally, female mice need

approximately six weeks of weekly hormone treatments and testing sessions to achieve
maximal copulatory behavior [47], while rats only need a maximum of two hormone
treatments and one training session before displaying maximal copulatory behavior [7].
The experiments discussed above were conducted before information regarding the
optimal hormone and practice levels to achieve maximal copulatory behavior in mice was
published.

The mice in this experiment were not trained or administered hormone

treatments for six weeks, which may explain why the female mice displayed low levels of
receptivity (5 or more mounts and

6

more intromissions) compared to other experiments

where female mice average 22 mounts and 15 mounts with intromissions [50].
Males, rats or mice undergo a “stud versus dud” test to determine if they will be
suitable stimulus males for the experiment. If they do not show adequate copulatory
behavior (mounts and intromissions) after three sessions with receptive females; they are
not used with for experiments. Vigorous sexual behavior is important because the
experimental females can show high levels of rejection behavior. If the stud males are

R ep ro d u ced with p erm ission o f th e copyright ow ner. Further reproduction prohibited w ithout perm ission.

66

not good copulators, they will stop attempting copulation with the experimental females.
Male and female mice must also be acclimated to the pacing apparatus prior to
testing. If they are not, they will spend the majority of the testing session exploring the
pacing cubes instead of engaging in copulatory behaviors. The low levels of receptivity
and pacing behavior observed in this experiment may be attributed to lack of prior
habituating sessions and adequate hormone treatment. In subsequent experiments, more
habituation sessions and higher hormone doses were given and greater behavior was
found, (see subsequent experiments)
This experiment also examined monoamine levels in the striatum, Nacc, vertical
diagonal band, amygdala and VMN in female C57 mice. A positive correlation was
found between DA, DOPAC and HVA and total stimulations in the Nacc. These results
are consistent with previous results showing that DA mediates copulatory behavior in
female rats and hamsters [2, 24]. Previous research has shown elevated DA levels in the
striatum and Nacc when rats or hamsters are allowed to copulate [3, 138]. These
increases were even larger in the striatum and Nacc when females were allowed to pace
their copulations. [2] [139] [3].
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VII. Experiment 2 - Effects of Apomorphine (20 fig, 60 fig and 120 fig) Pacing
and Receptive Components of Copulatory Behavior in C57 Female Mice

In the previous experiment, a method for measuring pacing behavior in female
mice was established. Using this method allowed for several observations. The first is
that female mice do pace in a similar manner, but at a lesser rate, than female rats (see
Table 1). In addition, consistent with previous rat studies we found that DA and its
metabolites increased in the Nacc as a function of sexual stimulations received (see Fig
10). This pattern indicated that DA in the Nacc, has a mediating role in copulatory
behavior in female mice. Numerous female rat studies report similar results [2, 3, 139].
DA increases in both the striatum and Nacc when females have been exposed to male rats
as well as when allowed to pace copulation [2,3, 9,122,139].
APO is a general DA agonist that binds to both Di and D 2 receptors and can be
used to examine the role of DA in regulating behaviors. Various doses of APO were
administered (2 0 , 60,

120

pg) and motivational and receptive components of copulatory

behavior of female mice were measured.
Specific Aim
Assess the role o f DA and its receptors in specific brain areas on receptive and
motivational aspects o f sexual behavior.
Hypothesis
Previous studies examining DA levels during copulation have found that DA
increases in the striatum and Nacc during paced copulation [2, 3, 139]. Therefore it is
hypothesized that administering APO, the DA receptor stimulating drug, to OVX female
mice will cause an increase in pacing and receptive behavior.
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Animals
Four groups o f 7-14 OVX female C57 mice were used. The first group received
saline and served as controls. The rest received 20 pg, 60 pg, or 120 pg of APO. Animal
care is outlined in the general experimental methods.
Injections
All female mice received 10 pg o f estrogen 48 and 24 hours before testing and
500 pg of progesterone five hours before testing. Each group received a subcutaneous
injection o f APO or saline 15 minutes before behavioral testing began.
Experimental Methods
The behavioral testing methods are outlined in the general experimental methods.
Statistical Analysis
One way ANOVA was used to analyze data. If ANOVA was significant at p <
0.05, Fishers LSD, a post hoc test, was used to test specific differences between groups.
Results
Using the receptivity chart (see Table 2), all groups treated with APO displayed
low to medium levels of receptivity while the control group displayed high levels of
receptivity. The group treated with 60 pg APO received significantly fewer mounts than
the control group (Ty 41 = 2.90, p < 0.05) (see Fig 14). Intromissions were also decreased
groups treated with APO, but this effect did not reach statistical significance.
Pacing was generally increased by APO. The group treated with 120 pg of APO
spent significantly more time in the neutral cubes after receiving an intromission than the
control group, the 20 pg APO group and the 60 pg APO group (p3 ; 13 = 6.83, p < 0.05)
(see Fig 15). Other measures o f pacing did not show a statistically significant increase.
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Figure 14: The effects of apomorphine on receptive behaviors. Data are mean ± SE
number or percentage of stimulations after treatment with saline, 20 pg, 60 pg or
120 pg of APO (n = 7 to 14 per group). Data w ere analyzed by one way ANOVA.
Fishers LSD, post hoc test, showed that the group treated with 60 pg of APO
received significantly less mounts than the control group (F3,4i = 2.90, p < 0.05).
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Figure 15: The effects of apomorphine on pacing behaviors. Data are mean ± SE
number or percentage of stimulations after treatment with saline, 20 pg, 60 pg or
120 pg of APO (n = 7 to 14 per group). Data are analyzed by one way ANOVA.
Fishers LSD, post hoc test, showed that the group treated with 120 pg of APO spent
significantly more time in the neutral cubes after receiving an intromission than the
control or other treatment groups (F3 , 13 = 6.83, p < 0.05).
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Discussion
Previous studies in female rats found increases in both pacing and receptive
behavior when dopamine levels increased [2, 3, 9, 20, 22, 122], Data from this
experiment partially agreed with the results of those studies. The results illustrated that
APO is associated with a dose dependent increase in pacing behavior (see Fig. 15), but a
dose dependent decrease of receptive behavior (see Fig. 14). Specifically the group
treated with 120 pg of APO spent significantly more time in the neutral cubes after
receiving an intromission than the control and other treatment groups. Although not
significant the group treated with 120 pg of APO spent more time in the neutral cubes
after receiving a mount, less time overall with the male and a greater percentage of time
overall in the neutral cubes (see Fig. 15).
Pacing parameters increased with APO treatment however receptivity decreased,
particularly at the 60 pg dose. The group treated with 60 pg of APO received
significantly less mounts than the control group. While not significant, the group treated
with 60 pg of APO also received less intromissions compared to the control group. The
dose dependent increase in pacing behavior seen at the

120

pg dose and dose dependent

decrease in receptivity seen at the 60 pg dose indicates that receptive parameters are more
sensitive than pacing parameters.
These relationships in the data may be explained by considering APO’s affinity
for pre and postsynaptic DA receptors and consequent effects on behavior. Generally,
low doses of APO produce hypomotility while higher doses induce stereotyped behavior
[92]. The dose dependent behavior may be related to the higher affinity of APO for
presynaptic DA receptors than for postsynaptic DA receptors. At lower doses, APO acts
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as an antagonist by activating presynaptic receptors. This causes an inhibition of both DA
synthesis and release [4], At higher doses, APO activates both presynaptic and
postsynaptic receptors, increasing transmission and therefore acting as an agonist [4],
The activation of pre and postsynaptic behavior by APO has been shown with
other behaviors. Self administration stimulation thresholds were measured in rats treated
with five doses of APO and trained to press a lever that delivered electrical stimulation to
the lateral hypothalamus [99]. Experiments examining the effects of increasing doses of
APO on thresholds of self administered electrical stimulation to the hypothalamus found
a significant behavioral difference at the lower doses versus the higher doses [99]. Low
doses caused thresholds to increase while the two higher doses caused thresholds to
decrease [99]. The authors indicate that increased thresholds at lower doses may reflect
APO activating presynaptic receptors, which leads to an inhibitory effect and causes
more stimulation to be necessary to have the same effect. Subsequently, the higher doses
cause thresholds to decrease which indicates the shift of APO from activation of
presynaptic receptors to postsynaptic receptors. This change in receptor stimulation
causes less stimulation to result in the same effect [99]. Another study examining the
effect of APO on locomotor activity found that there is a significant behavioral difference
between low and high doses of APO [96]. Low doses induced yawning which reflected a
selective activation of presynaptic DA receptors, while higher doses induced stereotyped
sniffing and yawning indicating postsynaptic D2 receptor activation [96].
Presynaptic behavioral inhibition as well as inhibition of DA release may
underlie the decrease in receptivity induced by a lower dose of APO (60 pg).
Hypomotility and decreased locomotor behavior may cause the female to display less
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receptive behaviors. In addition, decreased receptivity can lead to increased pacing
because the female is now utilizing the cubes to withdraw and escape the male. Higher
doses of APO are recruiting postsynaptic receptors which will lead to increased DA
synthesis and release. The increase in pacing behavior was seen in the highest dose (120
pg) of APO. In the current experiments with female mice and past experiments with
female rats [2, 3], increased DA release is correlated with increased pacing behavior,
inferring that pacing is a rewarding behavior. An increase in DA may explain past
studies which reported that both male and female rats treated with APO showed an
increase in receptive behavior [20, 22,128, 129], however we did not see this change in
behavior. When female mice were administered higher doses of APO (180 pg), we
expected to see further increases in pacing behavior and increases in receptive behavior.
However, no changes were found in either pacing or receptive behavior (unpublished
observations).
Mechanisms which could account for these differences in the behavioral
responses to APO between rats and mice are unknown. However, in the next section
(Experiment 3), levels of DA and metabolites as well as other mononamines were
measured in brain areas o f treated mice in order ot better understand effects o f APO.
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VIIL Experiment 3 - Effects of APO (20 pg, 60 pg and 120 pg) of APO to female
mice to examine neurochemical changes

Rationale
Experiment 2 showed significant behavioral differences between subjects treated
with APO compared to control subjects (see Figs. 14-15). Subjects treated with higher
doses of APO showed increased pacing behavior but decreased receptive behavior, as
compared to controls. These differences in behavior may be attributed to the activation
of pre and postsynaptic DA receptors. APO has a higher affinity for presynaptic DA
autoreceptors than postsynaptic DA receptors and therefore at low doses, acts as an
antagonist and decreases DA transmission [4]. At higher doses DA transmission is
increased because APO acts as an agonist by acting on postsynaptic receptors [4],
These behavioral results could also be due to monoaminergic changes,
particularly DA level changes in the striatum, Nacc and VMN which are induced by
APO. Therefore, DA and metabolites were measured in brain areas after 20, 60, and 120
pg of APO. Monoaminergic changes may underlie the increases in pacing behavior and
decreases in receptive behavior caused by APO and the differences in the behavioral
responses between rats and mice.
Specific Aims
Assessment of effects o f various doses of APO on DA levels and metabolites in
the striatum and Nacc, areas responsible for pacing, and VMN, area responsible for
receptivity.
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Hypothesis
Experiment 3 showed treatment with APO caused a dose dependent increase in
pacing behavior and a dose dependent decrease in receptive behavior. Receptivity was
more sensitive to apomorphine than pacing because receptivity decreased at 60 pg while
pacing increased at 120 pg. It is hypothesized that the treatment groups, specifically the
group treated with 120 pg will have higher levels of DA in the Nacc and striatum than the
control groups, while the group treated with 60 pg of APO will have higher levels of DA
in the VMN.
Animals
Four groups o f 6-10 OVX female C57 mice were used. The first group received
saline and served as controls. The rest received 20 pg, 60 pg, or 120 pg of APO. Animal
care is outlined in the general experimental methods.
Injections
All mice received 10 pg of estrogen 48 and 24 hours before sacrifice and 500 pg
of progesterone five hours before sacrifice. Each group received a subcutaneous
injection of APO or saline 30 minutes before sacrifice.
Experimental Methods
No behavioral tests were given. Thirty minutes after injection with APO or
saline, the mice were sacrificed by rapid decapitation. Brains were quickly frozen for
neurochemical analysis.
Statistical Analysis
One way ANOVA was used to analyze data. If ANOVA was significant at p <
0.05, Fishers LSD, a post hoc test, was used to test specific differences between groups.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

76

Monoamine analysis
Brains were sectioned, micropunched, and analyzed for monoamine and
metabolite levels using HPLC analysis as outlined in the general experimental methods.
Results
The results illustrate several significant findings in the striatum, Nacc and VMN.
HVA/DA was significantly affected by APO treatment, and the group treated with 120
pg of APO had significantly lower HVA/DA levels in the striatum than the control and
the group treated with 60 pg of APO (F 3 .33 - 4.99, p < 0.005) (see Fig 16). Serotonin
was also affected by APO treatment and the groups treated with 20 pg and 60 pg of APO
had significantly lower serotonin (5-HT) levels in the striatum than the control and group
treated with 120 pg o f APO (F 3 , 3 2 = 6.32, p < 0.001) (see Fig 17). In the Nacc, 120 pg
of APO treatment significantly increased DA levels as compared to both the control and
60 pg groups (F 3 >23 ~ 5.57, p < 0.005) (see Fig 18). Groups treated with 20 and 120 pg
APO had significantly lower HVA/DA levels in the Nacc than the control group (F 3 , 2 3 =
3.66, p < 0.02) (see Fig 18). Finally, the group treated with 60 pg of APO had
significantly higher HVA levels in the VMN that the groups treated with 20 pg and 120
pg (F 3 , 2 0 = 2.95, p < 0.05) (see Fig 19). DA and DOPAC in the VMN showed a similar
pattern of change following APO, but the difference did not reach statistical significance.
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Figure 16: The effects of apomorphine on DA and metabolites in striatum. Data
are expressed as pg/pg protein (mean ± SE; n = 6-10 per group). Data are analyzed
by one way ANOVA. Fishers LSD, post hoc test, showed that HVA/DA levels were
significantly lower in the group treated with 120 pg of APO compared to both the
control group and the group treated with 60 pg of APO (F 3.33 = 4.99, p < 0.005)
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Figure 17: The effects of apomorphine on NE, 5-HT and metabolites in striatum.
Data are expressed as pg/pg protein (mean ± SE; n = 6-10 per group). Data are
analyzed by one way ANOVA. Fishers LSD ,post hoc test, showed the groups
treated with 20 and 60 pg of APO have significantly lower 5-HT levels than the
control group and group treated with 120 pg of APO (F 3 , 3 2 = 6.32, p < 0.001).
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Figure 18: The effects of apomorphine on DA and metabolites in Nacc. Data are
expressed as pg/pg protein (mean ± SE; n = 6-10 per group). Data are analyzed by
one way ANOVA. Fishers USB, post hoc test, showed the group treated with 120 pg
APO had significantly higher levels of DA (F 3 ,23 = 5.57, p < 0.005) and significantly
lower levels of HVA/DA along with the group treated with 20 pg of APO (F 3 , 2 3 =
3.66, p < 0.02).
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Figure 19: The effects of apomorphine on DA and metabolites in VMN. Data are
expressed as pg/pg protein (mean ± SE; n = 6-10 per group). Data are analyzed by
one way ANOVA. Fishers LSD ,post hoc test, showed the group treated with 60 pg
of APO had significantly higher levels of HVA in the VMN compared to groups
treated with 20 pg and 120 pg of APO (F 3 , 2 0 = 2.95, p < 0.05).
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Discussion
Treatment with APO led to a number of dose dependent changes in monoamines
in the striatum, Nacc and VMN. The group treated with 120 pg of APO had significantly
higher levels o f DA in the Nacc and significantly lower HVA/DA levels in the striatum
and Nacc compared to controls. The group treated with 60 pg of APO had significantly
higher HVA levels in the VMN that the groups treated with 20 pg and 120 pg. The
groups treated with 20pg and 60 pg of APO had significantly lower serotonin levels in
the striatum than the control and group treated with 120 pg of APO.
These monoaminergic results support the hypothesis and may provide an
explanation for the behavioral results from Experiment 3. Again, the results of
experiment 3 illustrated that APO caused a dose dependent increase in pacing behavior
(see Fig 15) and a dose dependent decrease in receptive behavior (see Fig 14). In this
experiment the group treated with 120 pg APO had significantly higher levels of DA in
the Nacc (see Fig 18), while that same dose induced significantly higher pacing behaviors
(see Fig 15). In addition, they had significantly lower HVA/DA levels in both the
striatum and Nacc (see Figs 16,18). The increase in Nacc DA and the decrease in the
HVA/DA ratio indicate that APO induces increased DA release and that DA is not
metabolized as rapidly as in controls (i.e. a decrease in turnover). Increased DA levels in
the Nacc along with increased pacing agree with previous reports with female rats that
pacing caused increased levels of DA in Nacc. The decrease in HVA/DA in the striatum
at the 120 pg dose of APO may have also contributed to the increased pacing of this
group [2, 3,139].

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

82

It is notable that treatment with 60 jig of APO was associated with a significant
increase o f HVA levels in the VMN (see Fig. 19) because this group also displayed the
lowest levels of receptivity, (see Fig 14) Inhibition of lordosis in female rats has
previously been correlated with increases of DA in the ventromedial hypothalamus [143,
144] Therefore the decreased receptivity displayed by this group may be due to the
increased activity of DA in this area.
APO treatment led to a u-shaped dose-response curve for 5-HT levels in the
striatum: in the two lowest doses, 5-HT was decreased as compared to controls and the
high dose of APO (see Fig. 17). 5-HT has an inhibitory effect on lordosis but this effect
is centered in the VMN [145, 146]. No changes in the VMN 5-HT were noted. Striatal
5-HT and DA interact in some aspects of psychoactive drug effects [147,148]. However,
the pattern of these changes does not correlate with pacing changes. Thus, possible
relationships of striatal 5-HT to the behaviors measured, if any, are unknown.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

83

IX. Experiment 4 - APO effects on locomotion
Rationale
Experiment 2 demonstrated that APO had a dose dependent inhibitory effect on
receptive behavior and a facilitatory effect on pacing behavior. This pattern could be
explained by noting APO’s dose dependent activation effect on pre and postsynaptic
receptors [4]. At low doses, presynaptic DA receptors are activated while at high doses,
postsynaptic DA receptors are activated [4], Results of DA and metabolite measurements
in Experiment 3 were consistent with this hypothesis. However activation of pre and
postsynaptic receptors can also affect locomotor behavior [96], Specifically APO can
affect ambulations, grooming and stereotypy [92, 93].
While pacing behavior is a copulatory behavior [7] it also consists of locomotor
behavior since the female must approach and withdraw from the male. APO effects on
locomotor behavior, could have a profound effect on the female’s ability to pace
effectively. Therefore investigation of APO effects on locomotor behavior in female C57
mice is important for understanding the changes in copulatory behavior. In this
experiment the same doses (20 pg, 60 pg, and 120 pg) used in previous copulatory tests
were used to examine the effect of APO on locomotor behavior in an open field
apparatus. In addition, measures for exploration and anxiety were also made.
Specific Aim
Determine the effects of APO (20 pg, 60 pg, and 120 pg) on locomotor behavior in
female mice.
Hypothesis

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

84
Locomotor activity, exploration and anxiety will be correlated with APO dose, and
changes may be related to pacing or receptivity.
Animals
Four groups of 8 OVX female C57 mice were used. The first group received
saline and served as controls. The rest received 20 pg, 60 pg, or 120 pg of APO. Animal
care is outlined in the general experimental methods.
Injections
All mice received 10 pg of estrogen 48 and 24 hours before testing and 500 pg of
progesterone 5 hours before testing. Each group received an injection of APO or saline
15 minutes before behavioral testing began.
Experimental Methods
Mice were first acclimated to the task by placing them on the open field apparatus
for 15 minutes. The open field apparatus is a square (45cm by 45 cm), green, Plexiglas
open field. The height o f the four wails of the field is 20 cm. The field consists of a 4 by
4 grid and each grid is 10.5 cm by 10.5 cm.
Drug treatment and open field tests began 4 days after initial acclimation.
Tabulations were made for grid visits, rears (mice standing on hind legs), wall climbs
(mice standing on hind legs and placing front paws on wall), grooms (scratching and
cleaning fur) and defecations.
Statistical Analysis
One way ANOVA was used to analyze data. If ANOVA was significant at p <
0.05, Fishers LSD, a post hoc test, were used to test specific differences between groups.
Results
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All behavioral measures were altered in a dose-dependent manner by APO, and
significant differences were found in several of the locomotion measures following APO
treatment. Outer visits were increased by APO, and the group treated with 120 pg of
APO had significantly more outer visits than the control or group treated with 20 pg of
APO (F3, 28 ~ 4.34, p < 0.01) (see Fig 20). In contrast, inner visits, a measure of anxiety,
were decreased by APO. The groups treated with the highest doses of APO, 60 pg and
120 pg, had significantly less inner visits than the control group (F3>28 = 5.01, p < 0.006)
(see Fig. 21). All groups treated with APO displayed significantly less rearing behavior
than the control group (F3; 2 8 = 16.66, p < 0.0001). Rearing is related to exploration. The
groups treated with 60 pg and 120 pg o f APO displayed significantly less grooming than
the control group (F3; 2 8 = 8.28, p < 0.004) (see Fig. 21). Finally, the group treated with
120 pg of APO displayed significantly less wall climbs than the control group (F3>28 5.15, p < 0.005) (see Fig. 21).
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Figure 20: The effect of apomorphine on outer visit in open field apparatus. Data
are mean ± SE number of outer visits after treatment with saline, 20 pg, 60 pg or
120 pg of APO (n = 8 per group). Data were analyzed by one way ANOVA. Fishers
LSD post hoc test, showed the group treated with 120 pg of APO had significantly
more outer visits than the control or group treated with 20 pg APO (F3,28 = 4.34, p <
0.01).
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Figure 21: The effect of apomorphine on inner visits in open field apparatus. Data
are mean ± SE number of inner visits after treatment with saline, 20 pg, 60 pg or
120 pg of APO (n = 8 per group). Data were analyzed by one way ANOVA. Fishers
LSD post hoc test, showed the groups treated with 60 pg and 120 pg had significantly
less inner visits than the control group (F 3,2s = 5.01, p < 0.006).
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Figure 22: The effects of apomorphine on rearing behavior, wall climbing and
grooming behavior. Data are mean ± SE number of rears, wall climbs and
grooming behavior after treatment with saline, 20 pg, 60 pg or 120 pg of APO (n = 8
per group). Data were analyzed by one way ANOVA. Fishers LSD post hoc test,
showed all groups treated with APO (20 pg, 60 pg and 120 pg) displayed
significantly less rearing (F^as = 16.66, p < 0.0001), while the groups treated with 60
pg and 120 pg APO showed significantly less grooming behaviors (F3,28 = 8.28, p <
0.004) than the control group. The group treated with 120 pg displayed significantly
less wall climbing behavior ( F3,28 = 5.15, p < 0.005) than the control group.
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Discussion
The results support the hypothesis that behaviors on an open field, especially
locomotion behavior would be correlated with APO dose. Outer visits increased with
increasing APO doses, and the data showed a significant increase in outer visits, which is
a measure o f locomotor activity, in the group treated with the 120 pg of APO compared
to controls (see Fig 20). In contrast, APO significantly decreased rearing and wall
climbing, which are measures of exploratory behavior, compared to controls (see Fig 22).
APO also significantly decreased the number of inner visits, an indirect measure of
anxiety behavior [149], in the groups treated with 60 pg and 120 pg APO compared to
controls (see Fig. 21). Finally APO decreased grooming behavior in the groups treated
with 60 pg and 120 pg compared to controls (see Fig 22).
APO generally induces increased locomotion and stereotyped behavior such as
sniffing and licking at high doses [94]. At lower doses, APO can induce hypomotility
[92], however in C57 mice APO enhances locomotor activity [93]. The current data
suggests that APO had a significant excitatory effect on locomotor activity (outer visits).
However, APO had an inhibitory effect on exploratory behavior and grooming behavior.
In addition APO increased anxiety levels (decreased inner visits). Comparing the number
of inner visits in an open field behavior is an indirect measure of anxiety, but not an
anxiety test [149]. This conclusion based on observations that rodents generally do not
like wide open areas since they are more susceptible to predators. Instead they prefer a
dark, enclosed area or in the case of the open field the area which is close to the
wall [149].
In a previous experiment examining APO’s effect on pacing and receptive
behavior, a dose dependent increase in pacing behavior and a dose dependent decrease in
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receptivity were seen. The same dose of APO (120 pg) was associated with an increase
in locomotor activity (outer visits) and an increase in pacing behavior. Thus, changes in
pacing behavior parallels increased outer visits in the open field paradigm. In addition a
dose dependent decrease (60 pg) in receptivity was seen in Experiment 2 and there is a
significant increase in anxiety (decreased inner visits) at the same dose in this
experiment. The increase in anxiety may be related to the significant decrease in
receptivity. If the female mouse is anxious, she may not show be able to remain still and
allow the male to mount. Thus, less receptive behaviors may be shown. In addition,
because of enhanced anxiety, she may show increased rejection behaviors such as
nipping and kicking the male [47].
Anxiety was also increased following 120 pg of APO. This dose also
significantly increased pacing behavior. The increased anxiety level may also contribute
to increased pacing behavior, because subjects spend more time inside the cubes to
escape the male. The mounting or intromitting o f the female by the male may further
increase anxiety levels and cause additional increased pacing behavior (retreating to the
safe neutral cubes). Increased anxiety levels in conjunction with increased locomotor
activity can lead to increased pacing behavior, but not decreased receptive behavior as
seen at the 60 pg dose. Enhanced locomotion would not contribute to the immobilization
required for lordosis. Decreased exploration (rearing and wall climbing) and grooming
may also indicate increased anxiety levels which may also lead to increased pacing and
decreased receptivity.
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X. Experiment 5 - Effects of specific Dj agonists and D2 agonists on copulatory
behavior in female mice.

Rationale
The previous three experiments have examined the effect of APO on copulatory
and locomotion. APO is associated with a dose dependent increase in pacing behavior
and a dose dependent decrease of receptive behavior. In addition, APO caused increased
locomotion, increased anxiety and decreased exploration. The observed behaviors may
be due to APO activating presynaptic and postsynaptic receptors which induce different
behaviors. In addition the role of Di and D2 receptors needs to be further investigated
because they have been shown to modulate pre and postsynaptic effects [96].
Di and D2 receptor activation also differentially effects sexual behavior in rodents
[23, 24,130,131]. Treatment with Di agonists had no effect on male sexual behavior
[130], but when substituted for progesterone in female rats, increased lordosis [23]. In
addition, administration of D2 agonists decreased receptivity in both male and female rats
[23,131]. The current experiment investigates the role of specific Di and D 2 agonists on
pacing and receptive behavior in female mice.
Specific Aims
Determine the effects of Di and D2 receptors on pacing and receptive sexual behaviors in
mice.
Hypotheses:
Administering Di agonists will increase receptive but not pacing behavior. Administering
D2 agonists will decrease both receptive and pacing behaviors.
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Animals
Seven groups of OVX female C57 mice were used. The first group received
saline and served as controls. Three groups received increasing (0.3,1.0, and 2.0 mg/kg)
doses of SKF 38393 (Dj agonist) [4] and three groups received increasing doses (.03, 0.1,
0.3 mg/kg) o f quinpirole (D2 agonists) [4]. Animal care is outlined in the general
experimental methods
Injections
All mice received 10 pg of estrogen 48 and 24 hours before testing and 500 pg of
progesterone 5 hours before testing. Each mouse is assigned to either the control group
or one of the eight treatment groups and received either an injection of SKF 38393,
quinpirole or saline 15 minutes before behavioral testing began.
Experimental Methods
The behavioral testing methods are outlined in the general experimental methods.
Statistical Analysis
One way ANOVA was used to analyze data. If ANOVA was significant at p

<

0.05, Fishers LSD, a post hoc test, was used to test specific differences between groups.
Results
There were no significant differences found between Di and D 2 treated subjects
on any of the pacing or receptive measures. The group treated with the low dose of
quinpirole spent a higher percentage of time after receiving an intromission with the male
than the group treated with the medium dose of quinpirole (F s, 119 = 3.28, p < 0.008) (see
Fig. 26). There were no significant differences found between any of the remaining
groups on either of the receptive parameters including mounts (F6, 125 ~ 0.71, p = 062)
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and intromissions (Fgs125 = 0.54, p = 0.75) (see Fig. 23). There were also no other
significant differences found between any o f the groups on any of the pacing parameters
including time spent with the male (F 6 , 1 2 5 = 1-27, p = 0.28), time spent in the neutral
cubes (F e, 125 - 1.43, p - 0.22), mount latency (F g; 125 = 0.77, p = 0.57), time spent with
the male after receiving a mount (F g, 1 2 5 = 1.74, p = 0.15), time spent in the neutral cubes
after receiving a mount ( F ^ 125 - 1.60, p = 0.18), percentage of times females exited
after receiving a mount ( F 6,125 - 1.22, p = 0.31), intromission latency ( F 6,119 = 1.57, p
= 0.17), time spent with the male after receiving an intromission (F g, 119 ~ 1.43, p =
0.22), time spent in the neutral cubes after receiving an intromission ( F gjig = 1.05, p =
0.39) (see Figs. 24-26).
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Figure 23: The effect of Di and D2 agonists on receptive parameters. Data are
mean ± SE number of stimulations after treatment with saline, SKF-38393 and
quinpirole (n = 18-20 per group). The control group is represented by the solid bar.
The groups treated with the Di agonist are represented by the open bars. The
groups treated with the D2 agonists are represented by the hatched bars. Data were
analyzed using a one-way ANOVA. Treatment with SKF 38393 or quinpirole had
no effect on mounts ((F^ns = 0.71, p = 062) or intromissions (F<j, 125 = 0.54, p = 0.75).
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Figure 24: The effect of Dj and D2 agonists on percentage time spent with the male
or in the neutral cubes. Data are mean ± SE percentage time after treatment with
SKF 38393 or quinpirole (n = 20 per group). The control group is represented by
the solid bar. The groups treated with the Di agonist are represented by the open
bars. The groups treated with the D2 agonists are represented by the hatched bars.
Data were analyzed by one way ANOVA. Treatment with SKF 38393 or quinpirole
had no effect on time spent with the male (F 6, 1 2 5 = 1.27, p = 0.28), time spent in the
neutral cubes (F 6, 125 = 1.43, p = 0.22)
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Figure 25: The effects of D* and D2 agonists on pacing parameters associated with
mounts.
Data are mean ± SE percentage time after treatment with SKF 38393 or quinpirole
(n = 20 per group). The control group is represented by the solid bar. The groups
treated with the Di agonist are represented by the open bars. The groups treated
with the D2 agonists are represented by the hatched bars. Data were analyzed using
a one-way ANOVA. Treatment with SKF 38393 or quinpirole had no effect on
pacing parameters associated with mounting including mount latency (F 6 , 125 = 0.77,
p = 0.57), time spent with the male after receiving a mount (F 6,125 = 1.74, p = 0.15),
time spent in the neutral cubes after receiving a lhount ( F 6 , 125 = 1.60, p = 0.18),
percentage of times females exited after receiving a mount ( F 6 , 125 = 1.22, p = 0.31)
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Figure 26: The effects of Di and D2 agonists on pacing parameters associated with
intromissions. Data are mean ± SE percentage time after treatment with SKF 38393
or quinpirole (n = 20 per group). The control group is represented by the solid bar.
The groups treated with the D* agonist are represented by the open bars. The
groups treated with the D2 agonists are represented by the hatched bars. Data were
analyzed using a one-way ANOVA. If ANOVA was significant at p < 0.05 level,
Fishers LSD tested specific differences. Fishers LSD,/>as* hoc test, showed the
group treated with the low dose of the D2 agonist spent a significantly higher
percentage of time with the male after receiving an intromission than the group
treated with the medium dose (F 6, 11 9 = 3.28, p < 0.008). There were no other
significant finding on any intromission pacing parameters including intromission
latency ( F 6,1 1 9 = 1.57, p = 0.17), time spent with the male after receiving an
intromission (F 6, 119 — 1.43, p = 0.22), time spent in the neutral cubes after receiving
an intromission ( F 6,119 = 1.05, p = 0.39)
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Discussion
In Experiment 2 which examined APO’s mediating effects on copulatory
behavior, subjects treated with 120 pg of APO showed a dose dependent increase in
pacing behavior, while subjects treated with 60 pg of APO showed a dose dependent
decrease in receptive behavior. Di and D 2 receptor involvement was hypothesized to
have regulating effects, but further investigation was needed. Pacing and receptive
behaviors were measured following Di and D2 agonist treatment. Dose dependent
increases in receptive behavior were expected after treatment with SKF 38393 [23] and
dose dependent decreases in both receptivity and pacing were expected after treatment
with quinpirole [23, 131]. However none of these expected changes were seen in either
pacing or receptive behaviors. The group treated with the low dose of quinpirole spent
significantly more time with the male after receiving a mount than the group treated with
the medium dose (see Fig. 26). There were no other significant differences found in any
of the pacing or receptivity parameters between any of the treatment groups (see Figs. 2326). Several explanations may account for the results and they are discussed below.
Studies demonstrate that Di receptors mediate both pre and postsynaptic DA
receptors [96]. Examining the effects of Di agonists on APO induced behavior has
shown that Di agonists have different effects on low versus high doses of APO [96]. The
authors indicate that low doses of APO induce yawning which reflects a selective
activation o f presynaptic DA receptors; while high doses of APO induce stereotyped
sniffing which reflects postsynaptic D 2 receptor activation. SKF 38393, a Dj receptor
agonist, inhibited yawning induced by low doses of APO [96], The inhibitory effect of
SKF 38393 on APO induced yawning was attenuated by pretreatment with specific Di
receptor antagonist SCH 23390 [96], However, SKF 38393 potentiated sniffing induced
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by the high doses o f APO, without affecting gnawing [96]. These results indicate that Di
receptor activation modulates both pre and postsynaptic effects of APO in opposite
directions [96], The authors imply that Di receptor activation decreases presynaptic
effects but increases postsynaptic effects. When presynaptic DA receptors are stimulated
DA synthesis is inhibited by blocking the activity of tyrosine hydroxylase, the rate
limiting step in catecholamine synthesis [90, 150, 151]. In addition, presynaptic DA
receptor activation blocks DA release from presynaptic membrane-enclosed storage
vesicles and attenuates the firing rate of DA neurons [150,151]. Activation of Di
receptors inhibit presynaptic DA receptors activity, resulting in increased DA synthesis
and release [4]. When postsynaptic DA receptors are stimulated, DA transmission
increases. Therefore Di receptor activation of postsynaptic DA receptors may further
increase DA transmission.
When female rodents are allowed to pace their copulations, DA levels are
increased in the striatum and Nacc [2, 3,139]. This observation infers that paced
copulation is rewarding. However if there is already an increased level of DA available,
paced copulations may not be necessary, therefore pacing may not increase as it is no
longer needed for reward. This relationship may explain why increased pacing and
receptive behavior was not present as the doses of SKF 38393 increased.

If the

increasing doses of SKF 38393 increased DA synthesis and release, by inhibiting
presynaptic activity and stimulating postsynaptic activity, then receptive and pacing
behaviors may no longer have any additional rewarding value.
D2 receptors also modulate pre and postsynaptic receptor activity. An experiment
examined the effects o f Di and D 2 activation on pre and postsynaptic activity [100].
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Administering APO immediately before placing rats into a novel environment produced a
diphasic motility response (initial sedation followed by enhanced locomotion) [100].
Administering Di and D2 receptor antagonists can block APO induced inhibition of
locomotor behavior [100]. Antagonizing APO inhibition requires a higher affinity for D2
receptors [100]. Generally activation of D 2 receptors causes locomotor inhibition [100].
Therefore increased D2 binding and activation is needed to display increased locomotor
behavior [100].
As previously indicated, there was no difference on either pacing or receptive
behaviors within the groups that received quinpirole. This result may be due to the fact
that the doses were not high enough to bind and activate sufficient D2 receptors to inhibit
behavior. The doses were intentionally kept low so undesirable behaviors such as
immobility would not be induced [4], In addition D2 receptor activation of pre and
postsynaptic receptor activity must be considered. Because of the low doses used, there
may not have been enough available quinpirole to bind the needed amount of D2
postsynaptic receptors and induce an increased behavioral effect. If the doses are
inducing greater presynaptic receptor activity, there will either no change or a decrease in
behavior.
Generally when D2 agonists were administered to female rodents, copulatory
behavior was decreased [23, 131], The doses used in this experiment were based on
experiments with rats investigating the effects of quinpirole on sex behavior and
locomotion [131]. Similar results were expected in this experiment. D 2 binding and
presynaptic D2 activity is necessary to induce an inhibitory effect, while increased D2
binding is required to induce an excitatory effect. The low doses of quinpirole may not
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have been enough to stimulate D2 receptors, pre or postsynaptically, which may explain
why inhibition o f pacing and receptivity was not seen. Though not measured in this
experiment, the lack of D 2 binding may explain the lack of pacing and receptivity
inhibition.
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XI General Discussion and Conclusions
There were five experiments completed for this dissertation. Each gave
information that was important and furthered understanding of how monoamines mediate
copulatory behavior in the female mouse. Experiment 1 resulted in development of a
pacing paradigm for female mice and was used to determine baseline pacing and
receptive behaviors. Generally, female mice pace in a similar manner but at a lesser rate
than female rats. However, unlike female rats that show the lordosis posture when tested
after a small number of hormone treatments [12], female mice need weeks of hormone
treatments to show receptive behaviors [47], In addition, female mice demonstrated
increased DA levels in the Nacc as receptivity increased. Increases in DA levels in the
Nacc seen in this experiment as well as others [2,3], led to further investigation of DA
and its metabolites mediating pacing and receptivity.
APO was used to manipulate DA levels and investigate the resulting effect
on pacing and receptive behavior. Female mice were treated with three doses of APO (20
pg, 60 pg and 120 pg) and behavioral tests were conducted. Treatment with 120 pg of
APO caused increases in pacing while treatment with 60 pg caused decreases in
receptivity. The increased pacing behavior agreed with data from previous studies with
female rats [3,139] and hamsters [24], but the decreased receptive behavior did not. The
dose dependent relationships seen in the data may be explained by considering APO’s
affinity for pre or postsynaptic DA receptors. Low doses of APO are relatively selective
for presynaptic DA receptors which inhibit DA synthesis and release, while higher doses
of APO are relatively selective for postsynaptic DA receptors which have an excitatory
effect on DA transmission and release [4]. The lower doses may have only activated
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presynaptic DA receptors which may underlie the decreased receptivity seen at the 60 pg
dose. The higher doses may have activated postsynaptic DA receptors which may
underlie increased pacing behavior.
The results are also supported by the dopamine hypothesis of reward. The
hypothesis states that both priming and reinforcing effects o f rewarding brain stimuli
seem to be at least partially DA dependent [152]. Priming is defined as the motivating
effect of “free” reward given before an instrumental act [152]. Experiments have shown
that DA and DA agonists can prime food, cocaine and heroin seeking behaviors [152].
The 120 pg dose of APO may have primed pacing behavior. DA also contributes to pre
reward motivational arousal [152]. Immediate dopaminergic action is an amplifying
condition for pre-reward motivation [152]. Therefore, priming the animal with 120 pg
of APO may have amplified pre-reward motivation which may have caused an increase
in pacing behavior.
Experiment 2 examined the effects of increasing doses of APO on copulatory
behavior in female mice, but the effects of the treatment on DA containing neurons was
not measured. The following experiment (Exp 3) measured DA and metabolites in brain
areas of mice treated with APO to better understand APO’s effects. The group treated
with 120 pg of APO had significantly higher levels of DA in the Nacc and significantly
lower levels of HVA/D A in the striatum and Nacc compared to controls. Nacc DA
increases and HVA/DA ratio decreases indicate that APO induces increased DA release
and that DA is not metabolized as rapidly as in controls (i.e. a decrease in turnover). The
same dose significantly increased pacing behavior. Thus the change in concentrations is
correlated with the increased pacing seen in the previous experiments and previous
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reports. This relationship suggests that in mice as in rats [2, 3,139] and hamsters [24] the
mesolimbic DA system contributes to paced reproductive behaviors.
Treatment with 60 pg of APO induced significant increases of HVA in the VMN.
The same dose also induced the lowest levels of receptivity. HVA is a metabolite of DA,
indicating that there was increased in DA activity. This results agrees with several
studies that demonstrate an inhibitory effect of DA in the VMN on lordosis in female rats
[143,144], Decreased receptivity may be due to increased DA activity in the VMN.
This result is important because the VMN mediates reproductive behavior in female
rodents [53, 54], Therefore the decreased receptivity displayed by this group may be due
to the increased activity of DA in this area. These results further support the hypothesis
that there are different neural mechanisms underlying pacing and receptive components
of sexual behavior. The increase in DA in the VMN may underlie the receptive
component of female mouse behavior, while DA in the Nacc, may be the underlying
mechanism o f pacing behavior.
Pacing is a copulatory behavior but also consists of locomotor behavior.
Numerous studies have demonstrated that APO has both excitatory and inhibitory effects
on locomotor behavior [92, 93]. This information is relevant to this dissertation because
pacing and receptive behavior heavily involves locomotor behavior. If locomotor
behavior is compromised, copulatory behavior can be directly affected. Therefore it was
important to examine the effects of the previously used doses (20 pg, 60 pg, and 120 pg)
of APO on locomotion. An open field apparatus was used so that locomotion as well as
exploratory behavior and anxiety was measured. APO increased locomotor behavior and
anxiety, while decreasing exploratory behavior. At the 120 pg dose of APO, an increase
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in locomotion, anxiety and pacing behavior were observed. Thus changes in pacing
behavior parallels increased locomotion. Increased anxiety may also contribute to
pacing, if the APO treated subjects are more anxious they may be more likely to pace as
they may want to escape from the male. In addition, at the 60 pg dose, a decrease in
receptivity was seen and there was also a significant increase in anxiety. The increase in
anxiety may contribute to the significant decrease in receptivity.
The previous experiments focused on the effects of APO on copulatory and
locomotor behaviors. APO increased pacing behavior, anxiety and locomotor behavior in
a dose dependent manner while decreasing receptive and exploratory behavior in a dose
dependent manner. These results led to further investigation of how DA mediates pacing
and receptive behavior by specifically using Dj and D2 receptor agonists. Di and D 2
receptors differentially effect copulatory behavior in rats [23, 130, 131]. Dose dependent
increases were expected after treatment with Di agonists and dose dependent decreases
were expected after treatment with D2 agonists [23, 130,131]. However neither agonist
had an effect on pacing or receptive behavior. Di and D2 receptor activation effects on
pre and postsynaptic DA receptors may explain the results.
Studies have shown that Dj receptor activation decreases presynaptic effects [96].
When presynaptic DA receptors are stimulated, DA synthesis is inhibited because activity
of tyrosine hydroxylase is blocked, DA release from presynaptic membrane-enclosed
storage vesicles is blocked and the firing rate o f DA neurons is attenuated [150, 151]. Dj
receptor activation inhibiting presynaptic DA receptors may result in increased DA
synthesis and release [4], Postsynaptic DA receptor activation increases DA transmission
and Dj stimulation of postsynaptic DA receptor may further increase DA transmission.
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Generally pacing and receptive behaviors are correlated with increased DA in the
Nacc and striatum [2, 3,139]. Di agonists may have increased Nacc and striatum DA
transmission in the female mice. If DA transmission increased because of treatment with
Di agonists, less pacing behavior or receptive behavior may be needed for reward. This
may explain why there were no changes in copulatory behavior in mice treated with the
Di agonist.
Mice treated with the D2 agonist displayed no changes in copulatory behavior.
Generally D 2 binding and presynaptic D2 activity are necessary to activate an inhibitory
effect, while increased D2 binding is required to activate an excitatory effect [100].
Expected decreases may not have been seen because low doses of quinpirole used may
not have been enough to stimulate D2 binding and activate presynaptic receptors which
may explain the lack of change in behavior. Therefore the lack of decrease in both
pacing and receptive behavior may be due to the lack of sufficient binding.
In conclusion, female mice display both receptive and pacing behaviors. DA
regulates these behaviors through action in the Nacc, striatum and the hypothalamus.
APO caused dose dependent increases in pacing and dose dependent decreases in
receptivity. APO also caused dose dependent increases in DA levels in the Nacc and
HVA in the VMN which correlated with the behavioral changes. Though Dj and D2 can
influence pre and postsynaptic effects on copulatory behavior in opposite directions [23,
130,131], there were no differences in either pacing or receptivity when female mice
were treated with Di and D2 agonists.
Future controlled studies are needed to examine the effects of copulatory behavior
on DA transmission as well as the effect o f DA transmission on copulatory behavior.
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Further experiments measuring DA receptor binding after treatment with APO during
sexual testing, particularly during pacing and receptive behaviors are needed to
understand how DA receptors mediate these behaviors in female mice. Extracellular DA
levels during pacing and receptivity behavior should also be measured in female mice as
they have been done in female rats [2].
Though useful information was collected, there were shortfalls that may have
affected results that warrant further discussion. Copulatory behavior in female mice was
studied. However all experiments in this dissertation used female mice that were
displaying low levels of receptivity. Mice need six weeks of hormone treatment and
weekly testing before they show maximal receptive behavior [47]. Unlike female rats
that will show maximal sexual behavior after being hormone primed and tested a small
amount of times [12] mice need a longer period to become fully receptive [48]. The
experiments for this dissertation were based on rat studies which is why female mice
were tested after 2 weeks o f hormone treatment and testing. Future experiments
examining sexual behavior in female mice should allow ample time for hormone priming
and weekly testing until maximum receptivity is achieved. If the experiments had
allowed for increased hormone priming and weekly testing, it is expected that some of
the results may have been altered.
Another potential confound was the potential activation of pre and postsynaptic
DA receptors. Low doses o f APO activate presynaptic DA receptors which cause a
decrease of DA synthesis and release [4], Therefore at low doses, APO acts as an
antagonist. High doses of APO activate postsynaptic DA receptors and acts as a DA
agonist. Being aware at what dose a drug acts as an agonist versus an antagonist is
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crucial for maintaining the validity of the experiment. APO was administered at various
doses and expected to act as an agonist. However, the lower doses may have been
antagonistic. Drugs acting as antagonists when they are expected to act as agonists may
compromise the data. In addition, any drug used during testing of pacing or receptive
behavior should first be tested to establish if the drug affects locomotor activity. If the
drug does affect locomotion, this change can interfere with the desired behavior of
interest.
Finally, even though the pacing apparatus used in these experiments successfully
allowed for observation and measurement o f pacing behavior, it could be improved. The
pacing cubes allowed for the female to escape the male and protected her on all sides.
However, if the pacing cubes could be darkened, they may be more effective. Darkened
cubes would take advantage o f mice’s preference to be in dark, hidden places [149].
Therefore the females would be less anxious and more comfortable entering the cubes
and acclimate to them faster.
The information gathered from this dissertation can be broadened to clinical use.
Currently clinical studies of human sexual behavior greatly depend on self reports of
sexual desire, function and pleasure [153]. Studying the interaction between sexual
behavior, neurotransmitter and endocrine regulation can be used to investigate sexual
dysfunctions such as vaganismus (inability to relax vaginal walls for entry), dyspareunia
(pain during intercourse), and infertility. Specifically, examining copulatory behavior
using a female mouse pacing apparatus can provide further information. Information can
be gathered to help investigate estrogen’s effects on sexual desire in relation to
menopause or women who are diagnosed with hypoactive sexual desire. It can also
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increase our knowledge of the relationship between oral contraceptives that contain
increased progesterone and subsequently have been reported to decrease sexual desire.
In addition many psychoactive medications that affect serotonin activity produce
sexual side effects, particularly selective serotonin reuptake inhibitors (SSRIs) which act
to increase serotonin levels and are associated with sexual side effects such as decreased
libido [154]. Using a pacing paradigm with mice can help find remedies which reverse
SSRIs induced sexual dysfunction. Additionally, antiparkisonian and antipsychotic
medication have been reported to impair sexual function [155]. However little research
has been done to examine how DA mediates female sexual dysfunction. A pacing
paradigm developed using female mice may be able to provide more insight.
Illicit drug use has been demonstrated to enhance [156] or inhibit sexual function
[156-159]. Cocaine enhances DA activity by blocking presynaptic autoreceptors and is
commonly believed to enhance sexual pleasure [160]. However chronic cocaine use can
impair sexual function [157, 158]. In addition, withdrawal from cocaine can produce a
temporary reduction in sexual desire [159],
Finally the various components of female mice copulatory behavior can be used
as an additional model to study the DA mesolimbic “reward” system. Currently study of
this system is mainly confined to drug addiction [55, 56] and food seeking models [161 163]. Copulatory behavior, particularly pacing behavior can be viewed as another
motivated or rewarding behavior that can be manipulated to study the mediating effects
of monoamines and metabolites within the mesolimbic DA system.
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